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ABSTRACT 
Chemical substances isolated from plants or microorganisms play a variety of roles in our 
society. They work as food sources, provide sustainable energy and cure diseases. 
In the first chapter, four natural products and their derivatives exhibiting antibacterial 
activities were introduced and their total synthesis were described. Biatriosporin D, indanostatin, 
dihydro eurotiumide B and naphthacemycin A9 are bioactive hydroquinone/quinone natural 
products. The acylation and intramolecular Friedel Crafts reaction were the keys steps to the 
construction of the quinone structure in biatriosporin D. The Hauser-Kraus annulation was 
successfully applied to the syntheses of hydroquinone structures in indanostatin, dihydro 
eurotiumide B and naphthacemycin A9. 
In the second chapter, two biobased pyrone compounds were utilized as the starting 
materials to synthesize a variety of chemical substances. Substituted isophthalates were 
synthesized from methyl coumalate and vinyl ethers. A variety of alkyl, aryl and heteroaryl 
isophthalates were prepared. Aldol reactions of dehydroacetic acid at the acetyl group with 




CHAPTER 1.    SYNTHESIS OF ANTIBACTERIAL COMPOUNDS 
1.1       Introduction 
Bacteria, tiny single-celled organisms, were the first life forms existing on earth. They are 
found all around us. Bacteria exist in the air we breathe, in the water we drink, in the soil we 
plant, on the surfaces we touch.1 Bacteria live on and even inside our bodies. Bacteria play 
essential roles in the earth’s ecosystem. They provide nutrients like phosphorus and nitrogen to 
plants, decompose dead organic substances, and contribute to the cycles of nature. For ourselves, 
most of bacteria in our bodies are harmless and beneficial.2 For example, they help degrade the 
foods that we take and detoxify the poisons we contact. However, some species of bacteria are 
pathogenic and cause infectious diseases, such as pneumonia, tuberculosis, syphilis and bubonic 
plague.3 One of the deadliest pandemics recorded in human history was the Black Death during 
the Late Middle Ages. It killed 75 to 200 million people in Eurasia and North Africa. The Black 
Death is now known to be caused by the bacterium Yersinia pestis.4 The disease is treatable by 
antibiotics. 
Antibiotics either kill or inhibit the growth of bacteria. They have been used for a 
thousand years. Ancient civilizations used various plant extracts, such as herbs and honey and 
even animal feces to treat infections.5 However, ancient practitioners could not precisely identify 
or isolate the active components. The modern antibiotics era began with the synthetic arsenic-
based pro-drug Salvarsan by Paul Ehrlich in 1909.6 This discovery was inspired by his work on 
dyes that certain chemical dyes only color some bacteria cells but not others. Salvarsan was used 
to treat syphilis in the first half of the 20th century. Later Salvarsan was replaced by Prontosil 
(Figure 1.1), the first systemically active antibacterial drug.7 Prontosil is a sulfonamide derivate 
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and was developed by a research team led by Gerhard Domagk at Bayer. This sulfonamide drug 
opened a new era in medicine.  
In 1928, Alexander Fleming accidentally discovered penicillin (Figure 1.1). Penicillin 
was introduced on a large scale because of the work of Howard Florey and Ernst Chain who 
managed to efficiently purify the antibiotic and develop the mass production process. Howard 
Florey, Ernst Chain and Alexander Fleming shared the 1945 Nobel Prize in Medicine for the 
discovery of penicillin and its curative effect in various infectious diseases. 
 
Figure 1.1    Structure of Prontosil and Penicillin. 
The introduction of penicillin marked the beginning of the so-called “golden era” of 
antibiotics. From 1935 to 1968, the number of new antibiotic substances launched for medical 
use dramatically increased. Twelve new classes were launched. However, after golden era, the 
discovery and development of new antibiotics are declining. Only two new classes were 
introduced between 1969 and 2003 (Table 1.1).8 
Most of the antibiotic we use today as medicines were discovered and introduced during 
the golden era. Antibiotics have significantly changed our modern medical history and extended 
the average human life by 23 years in the past 100 years.9 However, massive use and misuse of 
valuable antibiotics since their introduction has resulted in antibiotic resistance. Antibiotic 
resistance is the ability of bacteria to defeat the antibiotic designed to kill them. This makes 
existing antibiotic less effective and some infections now impossible to treat, like Methicillin-
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resistant Staphylococcus aureus (MRSA), and drug-resistant tuberculosis.10 Resistant bacteria 
are now widespread in most parts of the world and the number of people who have died from 
bacterial infections is increasing because the antibiotics have stopped working. Each year in the 
U.S., at least 2.8 million people are infected with antibiotic-resistant bacteria, and more than 
35,000 people die as a result. As long as new drugs keep coming, resistance is not a problem.  
Therefore, a need for the development of new antibiotics still remains a high priority.  















Table 1.1    History of introduction of new classes of antibiotics.  
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Most of the antibiotics in current use are natural products or natural product derivatives. 
Bacterial, fungal, plant, and animal extracts are being screened in the search for new 
antibiotics.11 In this chapter, four different antibacterial compounds discovered within past ten 
years were introduced and their syntheses were described. 
1.1.1    Biatriosporin D 
Biatriosporin D, a red powder, was isolated from the endolichenic fungus Biatriospora 
sp. (8331C) and reported by Lou and coworkers in 2016 (Figure 1.2).12 Biatriosporin D showed 
potent activity against Candida albicans strains resistant to fluconazole (an antifungal 
medication). The minimum inhibitory concentration of biatriosporin D with 80% reduction 
against the growth of Candida albicans was 16 μg/mL. The research on mechanism revealed that 
biatriosporin D inhibited the function of efflux pumps and reduced the transcriptional expression 
of the efflux-pump-related genes CDR1 and CDR2. 
            
Figure 1.2    Structure of biatriosporin D.  
Later, Lou and coworkers reported that biatriosporin D also displayed potent anti-
virulence activity by inhibiting adhesion, hyphal morphogenesis and biofilm formation of 
Candida albicans. Morphogenesis is the biological process that causes a cell, tissue or organism 
to develop its shape.13 Biofilm formation is a process where microorganisms attach to and grow 
on a surface and produce extracellular polymers that facilitate attachment and matrix formation, 
resulting in an alteration in the phenotype of the organisms with respect to growth rate and gene 
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transcription. Furthermore, Biatriosporin D prolonged the survival of worms infected by 
Candida albicans in vivo. Given the importance of bioactivity of biatriosporin D and that no 
synthesis has been reported so far, we were interested in making biatriosporin D from organic 
synthesis. 
1.1.2    Indanostatin  
Indanostatin was first isolated from the cultured broth of Streptomyces sp. RAI20, 
coming from a soil sample collected at Nagoya Castle Park by Hayakawa and coworkers in 2013 
(Figure 1.3).14 The compound, the first reported 1,3-indanone from bacteria, exhibits potent 
neuroprotective activity against glutamate toxicity. The neuroprotective activity was examined 
by the MTT (a yellow chemical) method using C6 rat glioma cells. C6 glioma cells were from rat 
neural tumors, induced by N-nitrosomethylurea. When C6 cells were treated with 100 mM 
glutamate for 24 hours, about 80% of the cells underwent cell death. Indanostatin partially 
protected C6 cells against glutamate toxicity with an EC50 (half-maximal effective concentration) 
of 130 nM.  
 
Figure 1.3    Structure of indanostatin. 
Neuroprotective activity refers to the relative preservation of neuronal structure and/or 
function.15 Glutamate is a powerful excitatory neurotransmitter that is released by nerve cells in 
the brain.16 It is responsible for nerve signaling, for passing chemical messages from one nerve 
cell to another. At normal concentrations, glutamate is crucial for brain functions such as 
learning and memory. However, at high concentrations, glutamate's increased cellular activity 
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results in over-excitation of nerve cells, which eventually leads to cell death. When glutamate 
causes cellular damage, it becomes glutamate toxicity. 
No synthesis of Indanostatin has been reported so far. Given the importance of 
neuroprotective activity against glutamate toxicity, we were interested in making Indanostatin 
from organic synthesis.  
1.1.3    Eurotiumide B 
Eurotiumide A and eurotiumide B were isolated from marine-derived fungus, Eurotium 
sp. XS-200900E6, from the gorgonian Subergorgia suberosa, by Wang and coworkers in 2014 
(Figure 1.4).17 Both compounds exhibited potent antifouling activities against the larval 
settlement of the barnacle Balanus Amphitrite with the EC50 values ranging from 0.7 to 22.5 
μg/mL. Eurotiumide A and B also displayed profound antibacterial activities against 
Staphylococcus epidermidis, Bacillus cereus, Vibrio anguillarum, and Vibrio parahaemolyticus. 
 
Figure 1.4    Structures of eurotiumide A and B. 
Biofouling organisms, like barnacles, bryozoans, mollusks, polychaete, pose a risk to 
maritime industries in tremendous economic losses and cause a series of environmental 
problems.18 In the past, the most used strategy to prevent biofouling is antifouling paints 
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containing copper, lead, mercury, arsenic, or organotins. These paints are effective but difficult 
to degrade in the environment. They are also toxic to other larger organisms, such as fungi and 
algae. Therefore, safer antifouling agents without biocidal properties are in urgent demand. 
Recently, natural products as antifouling agents have drawn the attention of chemists. 
Because of the importance of antibacterial and antifouling activities of eurotiumide A and 
B, Nakayama and coworkers reported the first total synthesis of both compounds in 2018 
(Scheme 1.1).19 They also revised the stereochemistry of eurotiumide A and eurotiumide B 
(Figure 1.4).  
Their synthetic plan started from 2,5-dihydroxylbenzaldehyde. Bromination, MOM 
(methoxymethyl ether) protection, and then the Julia-Kocienski olefination gave trans olefins. 
Asymmetric epoxidation, followed by epoxide opening reaction, gave a single isomer product. 
Palladium-catalyzed insertion reaction under carbon monoxide atmosphere followed by 
bromination generated the bromo substituted lactone. The Stille coupling reaction finally 
provided the eurotiumide A. When the brominated lactone was treated with the Mitsunobu 
reaction condition before the Stille coupling reaction, eurotiumide B was formed. The total 
syntheses' key features are the asymmetric epoxidation, epoxide opening, and palladium 
catalyzed insertion/lactonization cascade reaction. 
1.1.4     Naphthacemycin A9 
Naphthacemycin A9, isolated from Streptomyces sp. KB-3346-5, was reported by Omura 
and coworkers in 2017.20 It is comprised of naphthacene structure (A, B, C, and D-rings) and the 
asymmetric E-ring moiety (Figure 1.5). Naphthacemycin A9 exhibits both circumventing effect 
of β-lactam resistance and anti-MRSA activity (methicillin-resistant Staphylococcus aureus).21 It 
also showed potent anti-VRE (vancomycin-resistant Enterococcus) and linezolid-resistant 




Scheme 1.1    Total syntheses of (–)-eurotiumide A and (+)- eurotiumide B. 
 
Figure 1.5    Structures of naphthacemycins A9. 
Methicillin-resistant Staphylococcus aureus (MRSA) refers to a type of bacteria, resistant 
to several antibiotics.22 Several difficult-to-treat infections caused by MRSA have become 
challenging in the communities due to its high mortality rate. Currently, only a few anti-MRSA 
drugs, such as vancomycin, teicoplanin, linezolid, and daptomycin, are available to be used 
against MRSA infections. However, anti-MRSA drugs' side effects and the emergence of drug-
resistance strains, such as vancomycin-resistant Enterococcus and linezolid-resistant 
Staphylococcus aureus, require the development of new anti-MRSA drugs. 
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Naphthacemycin A9 is a good candidate. In 2017, Ōmura and coworkers reported its 
synthesis for the first time (Scheme 1.2).23 They started the reaction from trisubstituted aryl 
bromide. The Suzuki-Miyaura coupling reaction introduced D Ring. The Wulff-Dötz reaction 
followed by another Suzuki-Miyaura coupling reaction afforded C and A ring. Intramolecular 
Friedel-Crafts cyclization provided B ring. Overall, they completed the synthesis of 
naphthacemycin A9 in 16 steps. 
 
Scheme 1.2    First total synthesis of naphthacemycin A9. 
In 2018, Shia and coworkers reported the second total synthesis of naphthacemycin A9 
(Scheme 1.3).24 They started the synthesis from disubstituted benzyl alcohol. Biphenyl subunit, 
D ring and E ring, was constructed through a Suzuki-Miyaura coupling reaction. C ring was 
generated by a Hauser-Kraus annulation reaction. A and B ring were introduced during the 




Scheme 1.3    Second total synthesis of naphthacemycin A9. 
1.2       Results and Discussions 
1.2.1    Total synthesis of biatriosporin D 
Scheme 1.4 shows the retrosynthetic analysis of biatriosproin D. Biatriosporin D consists 
of a hydroxyl group, two carbonyl groups, a furan ring and a phenyl ring. As the hydroxyl group 
is a relatively reactive functional group, forming a hydroxyl group at a late stage could avoid 
unnecessary protections and deprotections. Selective demethylation from the intermediate 1 
could be achieved since one of the methoxy groups is in a carbonyl's ortho position. For the 
intermediate 1, the phenyl ring and furan ring could be connected by cross-coupling reactions. 
Two carbonyl groups could be installed by acylation reactions. The intermediate 1 could be 
synthesized by combining the following three parts; the phenyl part (triflate protected phenol), 
the furan part (methyl furan or furan boronic acid), and the dicarbonyl part. Two carbonyl groups 
could be installed in one step using oxalyl chloride. If multiple steps, ethyl chloroxoacetate is a 
choice. Since intermediate 1 can be synthesized by acylation and cross-coupling reactions, there 




Scheme 1.4    Retrosynthetic analysis of biatriosporin D. 
First, we tried route 1, the cross-coupling reaction followed by acylation (Scheme 1.5). 
Triflate activated phenol 2 reacts with 2-methyl furan in the presence of palladium acetate and 
triphenylphosphine to provide the product 4 in 57% yield. Then oxalyl chloride was used to 
attempt acylation with different Lewis acids.25-27 Only titanium tetrachloride gave product 1 in 
10% yield. Other Lewis acids, like aluminum chloride and tin tetrachloride, failed in the 
acylation reaction. 
 
Scheme 1.5   Synthetic route 1. 
Then we turned our attention to the stepwise acylation (Scheme 1.6). Acylation of ethyl 
chloroxoacetate catalyzed by aluminum chloride gave three major products.28 The first product 5 
arises from the acylation on the phenyl ring. The structure is supported by proton NMR data. 
Product 6 arises from the acylation on the furan ring. The carbonyl and phenyl group are on the 
same side. This is determined by an NOE (nuclear Overhauser effect) experiment. The third 
product 7 is the cyclic alcohol. It is supposed to be formed from intermediate 6. Since only 




Scheme 1.6    Acylation of ethyl chloroxoacetate. 
We then explored the second route, acylation followed by the cross-coupling reaction. 
We started from 3,5-dimethoxy phenol 8. Acylation of 8 using ethyl chloroxoacetate and 
titanium tetrachloride occurred and formed the product 9 in 93% yield.29 Triflate anhydride 
protected hydroxy group on phenol 9 and produced compound 10 quantitatively (Scheme 1.7). 
 
Scheme 1.7    Synthesis of 10. 
The next step is the cross-coupling reaction of compound 10 with (5-methylfuran-2-yl) 
boronic acid (Scheme 1.8). The furan boronic acid is quite unstable. It needs to be stored at a low 
temperature. We made the furan boronic acid from 2-methyl furan using butyl lithium and 
triethyl borate. The Suzuki-Miyaura reaction connected furan boronic acid and compound 10 and 
provided coupled product 11 in 94% yield. 
The hydrolysis of compound 11 with sodium hydroxide in ethanol-water provided the 
keto acid 12(Scheme 1.9). Conversion of the keto acid 12 into ortho-quinone 1 proved to be 
difficult. Fortunately, we found that reaction with CDI (carbonyl diimidazole) followed by 
titanium tetrachloride at -10 °C afforded product 1 in 63% yield.30 Carboxylic acid 12 reacted 
with CDI reacted to form amide 13. The intermediate 13 underwent a Lewis acid catalyzed 




Scheme 1.8    Synthesis of 11.  
 
Scheme 1.9    Hydrolysis of compound 11. 
 
Scheme 1.10    Synthesis of ortho-quinone 1. 
The proposed mechanism of CDI that participated in amide formation from carboxylic 
acids is shown in Scheme 1.11. The proton transfer goes first. The anhydride is then formed 
through the attack of the carboxylate to protonated CDI followed by the expulsion of imidazole. 





Scheme 1.11    Mechanism of CDI participated amide formation. 
Ortho-quinone 1 is poorly dissolved in most organic solvents. Attempted deprotection 
using boron trichloride, boron tribromide or aluminum chloride returned recovered starting 
material. Finally, lithium chloride in DMF (dimethylformamide) under reflux conditions for two 
hours selectively demethylated and produced biatriosporin D in 92% yield (Scheme 1.12).31  
 
Scheme 1.12    Synthesis of biatriosporin D. 
The first synthesis of biatriosporin D was accomplished in six steps from 3,5-
dimethoxyphenol. The overall yield is 50% and the key steps are CDI mediated acylation and 
lithium chloride promoted demethylation. 
1.2.2      Total synthesis of (±) indanostatin 
Indanostatin has a chiral carbon and its absolute configuration has not been determined. 
Scheme 1.13 shows the retrosynthetic analysis. Indanostatin could be synthesized from acetone 
addition to the triketone 14. The triketone could be obtained through oxidation of methylene 
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group on indanedione 15. The intermediate 15 could be formed by the Claisen reaction from the 
diester hydroquinone. For the hydroquinone, the Hauser-Kraus annulation from butanolide and 
dimethyl fumarate is a good choice for the formation. 
 
Scheme 1.13    Retrosynthetic analysis of indanostatin. 
The Hauser-Kraus annulation is the synthesis of naphthalene hydroquinones from 
phthalides and α, β-unsaturated carbonyl compounds under basic conditions (Scheme 1.14).32 
The phthalide is deprotonated first. The resulting anion underwent the Michael addition with an 
unsaturated carbonyl compound followed by the Dieckmann condensation. The resulting 
diketones are tautomerized to naphthalene hydroquinones.  Commonly used bases are LDA 
(lithium diisopropylamide), lithium tert-butoxide, or potassium tert-butoxide. The X group on 
phthalides should be an electron-withdrawing leaving group, like cyanide, sulfide or sulfone 
group. This reaction is named after Dr. Frank Hauser and Dr. George Kraus.33-35 
In the past, much research focused on the synthesis of naphthalene hydroquinones from 
phthalides.36 No one reported the synthesis of benzene-based hydroquinones from substituted 
lactones (Scheme 1.15). We first explored the phenylthio-substituted lactone reaction with 
16 
 
methyl acrylate and different bases (Table 1.1).37 Two products, the hydroquinone product in 
33% yield and the Michael addition product in 60% yield, were obtained when LDA (lithium 
diisopropylamide) was used. Potassium tert-butoxide generated many products. However, 
lithium tert-butoxide gave only hydroquinone 17. The yield was 82%. 
 
Scheme 1.14    The mechanism of the Hauser-Kraus annulation. 
 




Entry Base Temperature Yield 
1 LDA -78 °C to rt 17 in 33% and 18 in 60% 
2 KOtBu rt Many products 
3 LiOtBu -78 °C to rt 17 in 82% and no 18 
Table 1.1    Hauser-Kraus annulation of 5-phenylthiobutenolide. 
With the optimal conditions defined, other unsaturated esters were explored with 
butanolide 16 (Scheme 1.16). Methyl crotonate, methoxy substituted crotonate and dimethyl 
fumarate all gave only hydroquinones 19 to 21 in 57-77% yields. The product 21 could be used 
for the synthesis of indanostatin. 
 
Scheme 1.16    Substrates scope. 
Hydroquinone 21 was hydrolyzed into dicarboxylic acid 22 and then was converted into 
anhydride 23 with acetic anhydride under reflux conditions. Treatment of the anhydride with 
ethyl acetoacetate in triethylamine and acetic anhydride gave intermediate 24. Then hydrochloric 
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acid at 80 °C converted intermediate 24 to indanedione 15. The overall yield is 48% from 
hydroquinone 21 (Scheme 1.17).38   
The next step is to oxidize the methylene group to the carbonyl group in the presence of 
the hydroquinone. Strong oxidation agents should be avoided. NBS (N-bromosuccinimide) at 
room temperature dibrominated the methylene group. No bromination occurred on the phenyl 
ring. Then dibromo compound was heated in DMSO (dimethyl sulfoxide) to generate triketone 
14. The resulting triketone was treated with excess acetone in acetic acid to produce racemic 
indanostatin in 55% yield (Scheme 1.18).39  
 
Scheme 1.17    Synthesis of 15. 
 
Scheme 1.18    Synthesis of indanostatin 
The first synthesis of indanostatin was accomplished in six steps.  The overall yield is 
15%. Key steps are the Hauser-Kraus annulation and the NBS-DMSO oxidation. 
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1.2.3    Total synthesis of dihydro eurotiumide B 
Nakayama and coworker reported the first total synthesis of eurotiumide B in 2018.19 As 
part of a program to extend bioactive compounds' applications, we pursue the preparation of the 
eurotiumide B derivate. Here, a synthesis of dihydro eurotiumide B was described. 
Scheme 1.19 shows the retrosynthetic analysis. Dihydro eurotiumide B is a 1,4-
hydroquinone lactone. The lactone part could be made by intramolecular cyclization from this 
intermediate. The intermediate is a hydroquinone and it could be synthesized through Hauser 
Kraus reaction. As for the two oxygens, they can be installed by ring-opening of the epoxide. 
Two different routes could synthesize the intermediate. Route 1: Hauser Kraus reaction of a 
butanolide with a diene ester followed by epoxidation. Route 2: Hauser Kraus reaction of a 
butanolide with an epoxy acrylate. 
 
Scheme 1.19    Retrosynthetic analysis of dihydro eurotiumide B. 
We first tried route 1, the Hauser-Kraus annulation of butanolide 16 with methyl sorbate 
(Scheme 1.20). The reaction gave two major products when using lithium tert-butoxide. 
Compound 25 does not have the desired regioselectivity. While compound 26 could be used for 




Scheme 1.20    The reaction of methyl sorbate with 26. 
Epoxide 27 was generated from methyl sorbate using the method of Barrow.40 The 
Hauser-Kraus annulation using butanolide 16 and epoxide 27 afforded the lactone 28 in 71% 
isolated yield as shown in Scheme 1.21. The proposed mechanism is shown in Scheme 1.22. The 
reaction first formed the Hauser-Kraus annulation product 29. In situ epoxide opening provided 
the lactone 30. This step has a literature analogy in Moore's work, which showed that 
hydroquinones bearing good leaving groups in the benzylic position undergo substitution via a 
quinone methide type intermediate.41 The phenylthiolate group produced in the Hauser-Kraus 
annulation adds back to lactone 30 and finally compound 28 was obtained. The phenylthiol 
group and methyl group are in a cis relationship.   
 
Scheme 1.21    Synthesis of 28. 
In order to better understand the unexpected annulation result, commercially available 4-
methyl-5-hydroxybutenolide was converted to 31 using our standard conditions. Reaction with 
epoxy sorbate 27 under the same conditions used for 16 produced dihydroisocoumarins 32 and 
an isocoumarin 33 in a 1:2 ratio (Scheme 6). Treatment of mixture of compound 32 and 33 with 
triethylamine in dichloromethane gave the product 33 only. The overall yield for compound 33 is 
21 
 
69%.  The structure of the isocoumarin 33 was supported by comparison to the spectrum of 
paepalantine.   
 
Scheme 1.22    Mechanism of synthesis of lactone 28. 
 
Scheme 1.23    Synthesis of 32 and 33. 
The result from Scheme 1.21 might be applicable to the approach to dihydro eurotiumide 
B if the conditions for the replacement of the phenylthiol group with a methoxyl group could be 
identified.  After several experiments, we found that using sodium methoxide in methanol at 
room temperature provided a 54% yield of 9 (Scheme 1.24). 
In order to make dihydro eurotiumide B, building blocks 40 and 42 were prepared as 
illustrated in Scheme 1.25.42 Phosphonate ester 37 was synthesized from phosphonate 36 through 
condensation with isovaleraldehyde followed hydrogenation. Then phosphonate ester 37 reacted 
with the monoacetal of glyoxal to provide a mixture of isomeric esters which was then treated 
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with hydrochloric acid to hydrolyze the acetal and isomerize the mixture to a hydroxy butanolide 
39. Introduction of the phenylthio group using thiophenol and PTSA (p-toluenesulfonic acid) 
quantitatively afforded butanolide 40. Epoxidation of the commercially available ester 41 using 
MCPBA (meta-chloroperoxybenzoic acid) afforded 42 in 84% yield.  
 
Scheme 1.24     Synthesis of 34. 
 
Scheme 1.25    Synthesis of 40 and 42. 
The combination of 40 and 42 using lithium tert-butoxide from -78 °C to ambient 
temperature followed by addition of methanol generated compound dihydro eurotiumide B 
(Scheme 1.26) in 41% isolated yield.  The trans-relationship between the amyl group and the 




Scheme 1.26    Synthesis of dihydro eurotiumide B. 
This chemistry was also applied in the preparation of anhydrofusarubin lactone. Phthalide 
46 was readily available from hydroxy phthalide 45 using thiophenol and PTSA (p-
toluenesulfonic acid) in toluene at 80 °C. Hydroxy phthalide 45 was synthesized from aldehyde 
43 in two steps (Scheme 1.27). Reaction of 46 and epoxy sorbate 27 under conditions that had 
been successful with the phenylthiobutenolide afforded two products, hydroquinone 47 and 
benzofuran 48 in a 1.2:1 ratio in a 92% combined yield (Scheme 1.28).43   
 
Scheme 1.27    Synthesis of 46. 
 
Scheme 1.28    Synthesis of 47 and 48. 
The reaction of phthalide 46 with methyl sorbate afforded ester 49 in 81% yield as the 
only isolated product (Scheme 1.29). The rationale for the high selectivity for 1,4-addition is 





Scheme 1.29    Synthesis of 49. 
The first synthesis of dihydro eurotiumide B has been achieved in seven steps from 
phosphonate ester 35. The overall yield is 30%. Key steps are the tandem Hauser-Kraus 
annulation-reductive thiolation reaction. The highly regioselective annulation of phthalide 46 
with methyl sorbate affords an advanced intermediate for the synthesis of anhydrofusarubin 
lactone. 
1.2.4    Total synthesis of (±) naphthacemycin A9 
Naphtacemycin A9 is a 1,4 quinone with two hydroxyl groups. It has a chiral axis and the 
absolute configuration has not been determined. The C ring could be synthesized by a Hauser-
Kraus annulation from cyanide substituted phthalide and benzyl protected enone. The synthesis 
of the enone was reported from the literature. The biphenyl phthalide could be synthesized 
through the intramolecular cyclization of biphenyl ester. The Diels-Alder reaction of the diene 
with alkynes could generate the biphenyl ester.  The diene could be obtained through 
dehydration from the aldehyde (Scheme 1.30).  
The synthesis started from dimethoxytoluene 50 (Scheme 1.31). The Vilsmeier reaction 
using phosphoryl chloride and dimethylformamide provided the aldehyde 51 in 86% yield.44 






Scheme 1.30    Retrosynthetic analysis of naphthacemycin A9.  
 
Scheme 1.31    Synthesis of 52. 
TBS triflate (tert-butyldimethylsilyl trifluoromethanesulfonate) and triethylamine 
transferred enone 52 to silyl ether diene 53. The next step is the Diels-Alder reaction. The 
reaction of 53 with methyl 4,4-diethoxybutynoate (54),45 an electron-deficient dienophile, in a 
sealed tube at 170 °C for 40 hours afford a dihydrobiphenyl adduct 55. DDQ (2,3-dichloro-5,6-
dicyano-1,4-benzoquinone) oxidation at 80 °C gave biphenyl product 56. TBAF (tetra-n-
butylammonium fluoride) removed TBS group and hydrochloric acid hydrolyzed the acetal 
group to aldehyde 57. The overall yield is 63% in five steps from compound 52. Then the 




Scheme 1.34     Synthesis of 58. 
The conversion of 58 to phthalide 60 was achieved through cyanohydrin formation 
followed by cyclization. TMSCN (trimethylsilyl cyanide) reacted with the aldehyde group of 58 
catalyzed by potassium cyanide in the presence of 18-crown-6.46 Then the adduct underwent 
cyclization in acetic acid at 40 °C. The transformation gave a diastereomeric a ratio around 1:1. 
 
Scheme 1.35    Synthesis of 60. 
Phthalide 60 was then reacted with enone 6147 and lithium tert-butoxide in deoxygenated 
THF (tetrahydrofuran) from -78 °C to ambient temperature to produce a hydroquinone 62 which 
was oxidized in situ with DDQ to provide a naphthacene quinone 63, an analog of 
naphthacemycin A9, in two steps in 74% overall yield (Scheme 1.36). When the tetrahydrofuran 
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used in the Hauser-Kraus annulation not was deoxygenated, the compound 64 was the major 
product, which was supposed to be formed via oxidation of 62 followed by the Michael addition 
of cyanide. Similarly, with enone 6547, naphthacemycin A9 was prepared by the Hauser-Kraus 
annulation, removal of the benzyl group and oxidized 1,4 hydroquinone to racemic 
naphthacemycin A9. The yield is 68% in three steps. 
 
Scheme 1.36    Synthesis of 63. 
 
Scheme 1.37    Synthesis of naphthacemycin A9. 
Racemic naphthacemycin A9 was synthesized in nine steps, the overall yield is in 26%. 





1.3       Conclusion  
Total syntheses of four natural products and their derivatives exhibiting antibacterial 
activities were accomplished. The synthesis of biatriosporin D was started from the Friedel-
Crafts reaction of 3,5-dimethoxyphenol followed by triflate protection. The Suzuki-Miyaura 
reaction of the phenol triflate with a furan boronic acid followed by the hydrolysis afforded the 
keto acid. Conversion of the keto acid into the ortho-quinone was achieved by using carbonyl 
diimidazole followed by titanium tetrachloride. Lithium chloride selectively demethylated the 
ortho-quinone and provided biatriosporin D. The first synthesis of biatriosporin D was 
accomplished in six steps. The overall yield was 50%. Key steps are the acylation and selective 
demethylation.  
The synthesis of indanostatin started from the Hauser-Kraus annulation of the butenolide 
and dimethyl fumarate. The resulting hydroquinone was hydrolyzed to the diacid and was then 
cyclized to the anhydride. The anhydride was then converted into the indanedione. The oxidation 
of the indanedione using N-bromosuccinimide/dimethyl sulfoxide followed by the acetone 
addition afforded indanostatin. The first synthesis of indanostatin was accomplished in six steps. 
The overall yield is 15%. Key steps are the Hauser-Kraus annulation and N-bromosuccinimide 
and dimethyl sulfoxide oxidation. 
The synthesis of dihydro eurotiumide B was started from the Emmons condensation of a 
phosphonate with the monoacetal of glyoxal. The acetal hydrolysis and thiophenol addition 
afforded the butanolide. The Hauser-Kraus annulation of the butanolide with a mono-epoxide of 
a dienic ester followed by methoxide substitution provided dihydro eurotiumide B. The first 
synthesis of dihydro eurotiumide B was achieved in seven steps. The overall yield is 30%. Key 
steps are the tandem Hauser-Kraus annulation-reductive thiolation reaction. 
The synthesis of naphthacemycin A9 was started from the Vilsmeier reaction of 3,5-
29 
 
dimethoxytoluene and an aldol-dehydration reaction. The Diels-Alder reaction of the silyloxy 
diene with the alkyne and DDQ oxidation afforded the biphenyl. The phthalide was achieved 
through the cyanohydrin formation followed by the cyclization in acetic acid. The resulting 
phthalide underwent Hauser-Kraus annulation with an enone and produced the hydroquinone. 
The benzyl deprotection and DDQ oxidation afforded naphthacemycin A9. Naphthacemycin A9 
was synthesized in nine steps, the overall yield is in 26%. The key steps are the Diels-Alder 
reaction and the Hauser-Kraus annulation. 
1.4.      Experimental 
General Information 
All starting materials were purchased from Sigma-Aldrich, Ambeed, Alfa Aesar, TCI and 
Oakwood Chemical. Solvents were all purchased from Sigma-Aldrich and Fisher Scientific and 
were used as received with the following exceptions. Tetrahydrofuran was distilled from lithium 
aluminum hydride. All reactions were monitored by thin layer chromatography (TLC) and 1H 
NMR. All yields refer to separated yield after column chromatography unless indicated. TLC 
was obtained by silica plate using UV light as a visualizing agent or Potassium permanganate 
solution with heat. All columns were performed with silica gel 60Å, particle size 40-63 μm. 1H 
and 13C NMR spectra were acquired in CDCl3 or other deuterated solvents on a Varian MR-400 
or Bruker Avance III 600 MHz spectrometer. Chemical shifts were reported in parts per million 
from the solvent resonance as the internal standard (CDCl3: δH = 7.26 ppm, δC = 77.16 ppm; 
DMSO-d6: δH = 2.50 ppm, δC = 39.52 ppm; Acetone-d6: δH = 2.05 ppm, δC = 29.84 ppm; 
multiplicity was indicated as follows: s (singlet), d (doublet), t (triplet), q (quartet), p (pentet) and 
m (multiplet)). High-resolution mass spectra (HRMS) were recorded on an Agilent 6540 QTOF 
(quadrupole time of flight) mass spectrometer using ESI (electrospray ionization). Melting points 
were obtained on a Digimelt MPA160 instrument. 
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General Procedure and Selected Spectrum Data. 
 
Ethyl 2-(2,4-dimethoxy-6-(((trifluoromethyl)sulfonyl)oxy)phenyl)-2-oxoacetate (10). 
To a solution of 3,5-dimethoxyphenol (154 mg, 1.0 equiv) in dichloromethane (5.0 mL) was 
added titanium tetrachloride (208 mg, 1.1 equiv) at -20 °C. Ethyl chlorooxoacetate (150 mg, 1.1 
equiv) was added dropwise while maintaining temperature at or below -15 °C. The resulting 
reaction mixture was stirred for 4 hours. The reaction was quenched by addition of hydrochloric 
acid (aqueous, 2.0 M) and was extracted with dichloromethane twice. The combined organic 
solution was washed with water and brine. The organic solution was dried by sodium sulfate. 
The solvent was evaporated in vacuo and the residue was dissolved in dichloromethane (5.0 ml).  
To the solution was added pyridine (158 mg, 2.0 equiv) and the solution was cooled to 0 °C. To 
the reaction mixture, trifluoromethanesulfonic anhydride (338 mg, 1.2 equiv) was added 
dropwise and the mixture was stirred for an hour. The mixture was diluted with ethyl acetate and 
was washed with hydrochloric acid (aqueous, 2.0 M), water and then brine. The organic solution 
was dried by sodium sulfate. The solvent was evaporated in vacuo and the residue was purified 
by column chromatography on silica gel and triflate 10 was obtained as a yellow solid (358 mg, 
93%). 1H NMR (400 MHz, CDCl3) δ = 6.48 (d, J=2.2, 1H), 6.45 (d, J=2.1, 1H), 4.31 (q, J=7.1, 
2H), 3.85 (s, 3H), 3.82 (s, 3H), 1.32 (t, J=7.1, 3H). 13C NMR (100 MHz, CDCl3) δ = 182.80, 
165.19, 163.14, 162.29, 149.80, 118.62 (q, J=320.7), 110.88, 101.66, 97.86, 62.19, 56.67, 56.22, 




Ethyl 2-(2,4-dimethoxy-6-(5-methylfuran-2-yl)phenyl)-2-oxoacetate (11). Triflate 10 
(386 mg, 1.0 equiv), PdCl2(PPh3)2 (35.2 mg, 0.05 equiv), 5-methyl-2-furanboronic acid (190 mg, 
1.5 equiv) and tripotassium phosphate (425 mg, 2.0 equiv) were added into round flask. To the 
reaction mixture, degassed tetrahydrofuran (5.0 mL) was added. The mixture was heated under 
reflux condition overnight. After cooling down, the mixture was diluted with ethyl acetate and 
was washed with water and brine. The organic solution was dried by sodium sulfate. The solvent 
was evaporated in vacuo and the residue was purified by column chromatography on silica gel 
and coupling product 11 was obtained as a yellow oil (300 mg, 94%). 1H NMR (400 MHz, 
CDCl3) δ = 6.67 (d, J=2.2, 1H), 6.45 – 6.42 (m, 1H), 6.37 (d, J=2.2, 1H), 5.98 (dd, J=3.3, 1.0, 
1H), 4.18 (q, J=7.1, 2H), 3.82 (s, 3H), 3.75 (s, 3H), 2.25 (s, 3H), 1.20 (t, J=7.1, 3H). 13C NMR 
(100 MHz, CDCl3) δ = 186.77, 162.61, 161.62, 159.93, 153.31, 149.70, 132.55, 115.71, 110.51, 
108.02, 102.66, 97.53, 62.09, 55.99, 55.56, 13.98, 13.53. HRMS (ESI-QTOF) calcd for [M + 
H+]: 319.1176, found: 319.1183.   
 
2-(2,4-Dimethoxy-6-(5-methylfuran-2-yl)phenyl)-2-oxoacetic acid (12). To a solution 
of 11 (318 mg, 1.0 equiv) in ethanol (2.5 mL) and water (5.0 mL) was added sodium hydroxide 
(160 mg, 4.0 equiv) in ice-bath. The mixture was stirred at room temperature for 1 hour. After 
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the completion of the reaction, ethanol was removed in vacuo and the residue was acidified by 
conc hydrochloric acid under an ice-bath. The product 12 was obtained by filtration as a yellow 
solid (286 mg, 99%).  1H NMR (400 MHz, DMSO-d6) δ = 6.80 (d, J=2.1, 1H), 6.73 (d, J=3.3, 
1H), 6.60 (d, J=2.2, 1H), 6.18 (dd, J=3.2, 1.2, 1H), 3.86 (s, 3H), 3.76 (s, 3H), 2.22 (s, 3H). 13C 
NMR (100 MHz, DMSO-d6) δ = 188.91, 162.56, 161.94, 159.32, 152.67, 149.47, 130.72, 
115.67, 109.99, 108.33, 102.35, 97.66, 56.17, 55.71, 13.20. HRMS (ESI-QTOF) calcd for [M + 
H+]: 291.0863, found: 291.0867. 
 
6-Hydroxy-8-methoxy-2-methylnaphtho[1,2-b]furan-4,5-dione. To a solution of acid 
12 (145 mg, 1.0 equiv) in dichloromethane (3.0 mL) was added carbonyldiimidazole (162 mg, 
2.0 equiv). The reaction mixture was stirred at room temperature overnight. The resulting 
solution was added into a solution of titanium tetrachloride (380 mg, 4.0 equiv) in 
dichloromethane (2.0 mL) at -10 °C. The reaction mixture was stirred at -10 °C for 5 hours and 
quenched by addition of hydrochloric acid (aqueous, 2.0 M) and then was extracted twice with 
dichloromethane. The combined organic solution was washed with saturated sodium bicarbonate 
solution, water and brine. The organic solution was dried by sodium sulfate. The solvent was 
evaporated in vacuo and red solid 1 was obtained (87 mg, 63 %).  To a solution of solid 1 (54.4 
mg, 1.0 equiv) in dimethylformamide (6.0 mL) was added lithium chloride (50.4 mg, 6.0 equiv). 
The reaction mixture was heated under reflux condition for 2 hours and was cooled down. 
Dimethylformamide was removed by distillation under reduced pressure. And the residue was 
acidified by hydrochloric acid (aqueous, 2.0 M) and then was extracted three times by ethyl 
33 
 
acetate. The combined organic solution was washed with water and brine. The organic solution 
was dried by sodium sulfate. The solvent was evaporated in vacuo and the residue was purified 
by column chromatography on silica gel and product was obtained as red solid (47.4 mg, 92%). 
1H NMR (400 MHz, CDCl3) δ = 12.43 (s, 1H), 6.74 (d, J=2.3, 1H), 6.41 (s, 1H), 6.31 (d, J=2.3, 
1H), 3.90 (s, 3H), 2.40 (s, 3H). 13C NMR (100 MHz, CDCl3) δ = 182.12, 175.37, 169.22, 168.20, 
158.14, 156.31, 129.59, 122.78, 106.82, 105.39, 104.44, 101.26, 56.31, 13.78. HRMS (ESI-
QTOF) calcd for [M + H+]: 259.0601, found: 259.0597.  
 
3-Methyl-5-(phenylthio)furan-2(5H)-one (16). To a stirred solution of 5-hydroxy-3-
methylfuran-2(5H)-one (1.14 g, 10 mmol) in toluene (100 mL) was added p-toluenesulfonic acid 
(PTSA, 50 mg) followed by thiophenol (1.10 g, 10 mmol), and the mixture was heated at 80 °C 
for 15 hours. Toluene was removed under reduced pressure. The crude residue was then diluted 
with ethyl acetate (50 mL) and washed by water and brine and dried over sodium sulfate and 
concentrated. Purification by column chromatography gives the product as a solid 16 (1.80 g, 
87%). 1H NMR (400 MHz, CDCl3) δ = 7.64 - 7.46 (m, 2H), 7.40 - 7.28 (m, 3H), 6.96 (p, J=1.6, 
1H), 6.11 (p, J=1.9, 1H), 1.83 (t, J=1.8, 3H). 13C NMR (100 MHz, CDCl3) δ = 172.84, 144.96, 
134.12, 132.15, 130.20, 129.27, 129.15, 85.86, 10.59. HRMS (ESI-QTOF) calcd for [M + H]+: 
207.0474, found: 207.0470. 
General procedure for Hauser-Kraus annulation of 16 for the syntheses of 
compound 17, 19, 20, 21. 
To a stirred solution of 16 (206 mg, 1.0 mmol, 1.0 equiv) in tetrahydrofuran (3.0 mL) 
was added lithium tert-butoxide (1.0 M in THF, 3.0 mL, 3.0 equiv) at -78 °C. And the mixture 
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was stirred for 30 minutes at the same temperature. The unsaturated ester (1.5 equiv, 1.5 mmol) 
in tetrahydrofuran (1.0 mL) was added dropwise to the mixture and the mixture was stirred at -78 
°C for 30 minutes. Then the mixture was warm to room temperature and stirred overnight. 
Hydrochloric acid (aqueous, 2 M, 10 mL) was added to quench the reaction and the aqueous 
layer was extracted with ethyl acetate (10 mL x 2). The combined organic layers were dried over 
sodium sulfate and concentrated. Purification by column chromatography gives the product. 
 
Methyl 2,5-dihydroxy-3-methylbenzoate (17). White solid, 150 mg, yield = 82%. 1H 
NMR (400 MHz, CDCl3) δ = 10.61 (s, 1H), 7.10 (d, J=3.2, 1H), 6.89 (d, J=3.2, 1H), 5.54 (br, 
1H), 3.89 (s, 3H), 2.21 (s, 3H). 13C NMR (100 MHz, CDCl3) δ = 170.80, 154.32, 147.08, 128.15, 
125.17, 112.10, 111.42, 52.48, 15.91. HRMS (ESI-QTOF) calcd for [M - H]-: 181.0506, found: 
181.0502. 
 
Methyl 2,5-dihydroxy-3,6-dimethylbenzoate (19). White solid, 151 mg, yield = 77%. 
1H NMR (400 MHz, CDCl3) δ = 10.78 (s, 1H), 6.83 (s, 1H), 3.96 (s, 1H), 2.39 (s, 3H), 2.19 (s, 
3H). 13C NMR (100 MHz, CDCl3) δ = 172.41, 154.90, 145.75, 124.76, 123.91, 122.33, 112.68, 




Methyl 2,5-dihydroxy-6-(methoxymethyl)-3-methylbenzoate (20). White solid, 133 
mg, yield = 59%. 1H NMR (400 MHz, CDCl3) δ = 10.40 (s, 1H), 8.10 (br, 1H), 6.90 (s, 1H), 4.98 
(s, 2H), 3.95 (s, 3H), 3.44 (s, 3H), 2.21 (s, 3H). 13C NMR (100 MHz, CDCl3) δ = 171.21, 153.90, 
149.28, 127.88, 125.66, 118.16, 110.60, 72.36, 58.51, 52.51, 16.16. HRMS (ESI-QTOF) calcd 
for [M - H]-: 225.0768, found: 225.0771. 
 
Dimethyl 3,6-dihydroxy-4-methylphthalate (21). White solid, 136 mg, yield = 57%. 1H 
NMR (400 MHz, CDCl3) δ = 8.95 (s, 1H), 8.89 (s, 1H), 6.89 (s, 1H), 3.85 (s, 3H), 3.84 (s, 3H), 
2.21 (s, 3H). 13C NMR (100 MHz, CDCl3) δ = 169.87, 169.45, 152.14, 150.87, 134.80, 124.02, 
111.80, 109.74, 52.62, 52.53, 16.44. HRMS (ESI-QTOF) calcd for [M - H]-: 239.0561, found: 
239.0559. 
 
4,7-dihydroxy-5-methyl-1H-indene-1,3(2H)-dione (15). To a solution of 21 (240 mg, 
1.0 mmol, 1.0 equiv) in methanol (5.0 mL) and water (5.0 mL) was added sodium hydroxide 
(400 mg, 10.0 equiv) in ice-bath. The mixture was stirred at room temperature for 1 hour. After 
the completion of the reaction, methanol was removed in vacuo and the residue was acidified by 
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conc hydrochloric acid in ice-bath. The mixture was extracted with ethyl acetate (10 mL x 2) and 
the combined organic layers were dried over sodium sulfate and concentrated. The residue was 
dissolved in acetic anhydride (10 mL) and the mixture was heated overnight at reflux and then 
was cooled down. Acetic anhydride was removed by distillation under reduced pressure. The 
residue was dissolved in acetic anhydride (2.0 ml) containing triethylamine (1.0 mL) and the 
solution was treated with ethyl acetoacetate (156 mg, 1.2 mmol). After stirring overnight, 
hydrochloric acid (aqueous, 6 M, 10 mL) was added to the dark solution at room temperature. 
The solution was heated to 75 °C for 1.0 hour.  Aqueous layer was extracted with ethyl acetate 
(10 mL x 2). The combined organic layers were dried over sodium sulfate and concentrated. 
Hexane was added to the residue and solid was precipitated out. Product was collected by 
filtration. Brown solid, 92 mg, yield = 48%. 1H NMR (400 MHz, DMSO-d6) δ = 10.03 (s, 1H), 
9.17 (s, 1H), 7.05 (s, 1H), 3.23 (s, 2H), 2.19 (s, 3H). 13C NMR (100 MHz, DMSO-d6) δ = 
200.43, 195.76, 148.25, 146.48, 136.80, 127.19, 126.39, 124.63, 46.41, 16.15. HRMS (ESI-
QTOF) calcd for [M - H]-: 191.0350, found: 191.0353. 
 
2,4,7-trihydroxy-5-methyl-2-(2-oxopropyl)-1H-indene-1,3(2H)-dione (indanostatin). 
To a solution of 9 (92 mg, 0.48 mmol, 1.0 equiv) and ammonium acetate (3.7 mg, 0.048 mmol, 
0.1 equiv) in diethyl ether (5.0 mL) was added N-bromosuccinimide (170 mg, 0.96 mmol, 2.0 
equiv). The mixture was stirred at room temperature for overnight. After the completion of the 
reaction, the solution was diluted with diethyl ether (10 mL) and was washed with hydrochloric 
acid (aqueous, 1 M, 5 mL) followed by brine. The organic layer was dried over sodium sulfate 
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and concentrated. The residue was dissolved in dimethyl sulfoxide (1.0 mL) and heated at 80 °C 
for 2.0 hours. After the reaction was cooled down, water (1.0 mL) was added to the solution and 
the mixture was stirred at room temperature for 1.0 hour. Water and dimethyl sulfoxide were 
removed by distillation under reduced pressure. And the residue was diluted with ethyl acetate 
(20 mL) and washed with hydrochloric acid (aqueous, 1 M, 10 mL) followed by brine.  The 
organic layer was dried over sodium sulfate and concentrated. The residue was dissolved in 
acetic acid (1.0 mL) and a few drops of acetone were added to the mixture. The reaction was 
heated at 55 °C for 6 hours. After cooling down, acetic acid was evaporated in vacuo and the 
residue was diluted with ethyl acetate (10 mL) was washed with hydrochloric acid (aqueous, 1 
M, 5 mL) followed by brine. The organic layer was dried over sodium sulfate and concentrated. 
Purification by column chromatography gives the product as a yellow solid, 69.1 mg, yield = 
55%. 1H NMR (400 MHz, acetone-d6) δ = 8.64 (s, 2H), 7.19 (d, J=0.9, 1H), 3.39 (d, J=1.4, 2H), 
2.32 (d, J=0.8, 3H), 2.11 (s, 3H). 13C NMR (100 MHz, acetone-d6) δ = 205.63, 201.18, 198.51, 
149.11, 148.07, 137.65, 127.10, 122.73, 121.50, 73.62, 47.61, 28.49, 14.92. HRMS (ESI-QTOF) 
calcd for [M - H]-: 263.0561, found: 263.0561. 
 
Methyl (E)-2,5-dihydroxy-3-methyl-6-(prop-1-en-1-yl)benzoate (26). To a stirred 
solution of butanolide 16 (206 mg, 1.0 mmol) in tetrahydrofuran (5.0 mL) was added lithium 
tert-butoxide (1.0 M in tetrahydrofuran, 3.0 mL) at -78 °C (dry ice/acetone bath). The mixture 
was stirred for 30 minutes at the same temperature. Methyl sorbate (151 mg, 1.2 mmol) in THF 
(2.0 mL) was added dropwise to the mixture and the mixture was stirred at -78 °C for another 30 
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minutes. The mixture was warmed to room temperature and stirred 16 hours. Hydrochloric acid 
(aqueous, 2 M, 10 mL) was added to quench the reaction and the aqueous layer was extracted 
with ethyl acetate (10 mL x 2). The combined organic layers were dried over sodium sulfate and 
concentrated. Purification by column chromatography on silica gel (hexane/ethyl acetate = 20:1 
(v/v))  gave the product 26 as a yellow oil (62.10 mg, 28%, d.r =3/1, rf = 0.3(hexane/ethyl 
acetate = 10:1 (v/v))). 1H NMR (400 MHz, CDCl3)
 δ = 10.94 (s, 1H), 6.98 (s, 1H), 6.45 (dd, 
J=16.3, 2.0, 1H), 5.75 (dq, J=16.4, 6.5, 1H), 5.52 (s, 1H), 3.89 (s, 3H), 2.22 (s, 3H), 1.93 (dd, 
J=6.5, 1.8, 3H). 13C NMR (100 MHz, CDCl3){1H}: δ = 171.7, 154.6, 144.8, 129.8, 127.4, 126.9, 
123.8, 121.2, 109.8, 52.1, 18.5, 16.0. HRMS (ESI-TOF) m/z: [M + H]+ Calcd for C12H15O4 
223.0965; Found 223.0968. 
 
5,8-Dihydroxy-3,7-dimethyl-4-(phenylthio)isochroman-1-one (28). To a stirred 
solution of butanolide 16 (206 mg, 1.0 mmol) in tetrahydrofuran (5.0 mL) was added lithium 
tert-butoxide (1.0 M in tetrahydrofuran, 3.0 mL) at -78 °C (dry ice/acetone bath). The mixture 
was stirred for 30 minutes at the same temperature. The epoxide 27 (170 mg, 1.2 mmol) in 
tetrahydrofuran (2.0 mL) was added dropwise to the mixture and the mixture was stirred at -78 
°C for 30 minutes. The mixture was warmed to room temperature and stirred 16 hours. 
Hydrochloric acid (aqueous, 2 M, 10 mL) was added to quench the reaction and the aqueous 
layer was extracted with ethyl acetate (10 mL x 2). The combined organic layers were dried over 
sodium sulfate and concentrated. Purification by column chromatography on silica gel 
(hexane/ethyl acetate = 3:1 (v/v))  gave the product 8 as a solid (224 mg, mp:126-128 °C, 71%, 
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d.r =3/1, rf = 0.3(hexane/ethyl acetate = 3:1 (v/v))). 1H NMR (400 MHz, CDCl3) δ = 10.90 (s, 
1H), 7.51 - 7.44 (m, 2H), 7.38 - 7.30 (m, 3H), 6.99 (s, 1H), 4.91 (qd, J=6.8, 1.4, 1H), 4.90 (br, 
1H) 4.45 (d, J=1.3, 1H), 2.24 (s, 3H), 1.35 (d, J=6.8, 3H). 13C NMR (100 MHz, CDCl3){1H}: δ 
= 168.2, 154.9, 144.4, 134.6, 131.7, 129.3, 128.8, 128.0, 126.7, 118.5, 106.3, 78.4, 44.5, 20.2, 
15.8. HRMS (ESI-TOF) m/z: [M + H]+ Calcd for C17H17O4S 317.0842; Found 317.0841. 
 
4-Methyl-5-(phenylthio)furan-2(5H)-one (31). To a stirred solution of 5-hydroxy-4-
methylfuran-2(5H)-one (1.70 g, 10 mmol) in toluene (100 mL) was added p-toluenesulfonic acid 
(PTSA, 57 mg, 0.3 mmol) followed by thiophenol (1.10 g, 10 mmol), and the mixture was heated 
at 80 °C (oil bath) for 15 h. Toluene was removed under reduced pressure. The crude residue was 
then diluted with ethyl acetate (50 mL), washed by water and brine, dried over sodium sulfate, 
and concentrated. Purification by column chromatography on silica gel gave the product 6 as 
yellow liquid. 1.85 g, yield = 90%. 1H NMR (600 MHz, CDCl3) δ = 7.55 - 7.53 (m, 2H), 7.40-
7.34 (m, 3H), 6.02 (m, 1H), 5.77 (dt, J=2.9, 1.5, 1H), 2.18 (t, J=1.3, 3H).13C NMR (150 MHz, 
CDCl3) δ = 171.3, 164.7, 134.3, 129.3, 129.2, 128.9, 118.8, 89.1, 14.5.HRMS (ESI-TOF): m/z 
[M + H]+ calcd for C11H11O4: 207.0474; found: 207.0471. 
 
5,8-Dihydroxy-3,6-dimethyl-1H-isochromen-1-one (33). To a stirred solution of 
butanolide 6 (206 mg, 1.0 mmol) in tetrahydrofuran (3.0 mL) was added lithium tert-butoxide 
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(1.0 M in tetrahydrofuran, 3.0 mL, 3.0 mmol) at -78 °C (dry ice/acetone bath). The mixture was 
stirred for 30 min at the same temperature. The epoxide 27 (213.0 mg, 1.5 mmol) in THF (1.0 
mL) was added dropwise to the mixture, and the mixture was stirred at -78 °C for 30 min. The 
mixture was warmed to room temperature and stirred 16 h. Hydrochloric acid (aqueous, 2 M, 10 
mL) was added to quench the reaction, and the aqueous layer was extracted with ethyl acetate 
(10 mL × 2). The combined organic layers were dried over sodium sulfate and concentrated. 
Purification by column chromatography on silica gel gave a mixture of compound 32 and 33. 
The mixture was dissolved in dichloromethane (10 mL) and triethylamine (1.0 mL) and was 
stirred at room temperature for 24 hours. Hydrochloric acid (aqueous, 2 M, 10 mL) was added to 
quench the reaction, and the aqueous layer was extracted with dichloromethane (10 mL × 2). The 
combined organic layers were dried over sodium sulfate and concentrated. Purification by 
column chromatography on silica gel gave product 33 as a yellow solid. 142 mg, yield = 69%, 
mp 154-156 °C; 1H NMR (600 MHz, acetone-d6) δ = 10.51 (s, 1H), 6.74 (d, J=0.8, 1H), 6.72 (d, 
J=1.1, 1H), 2.36 (d, J=0.7, 3H), 2.29 (d, J=1.1, 3H). 13C NMR (150 MHz, acetone-d6) δ = 166.4, 
154.9, 153.0, 141.0, 136.1, 125.5, 115.6, 103.3, 99.1, 18.6, 16.6. HRMS (ESI-TOF): m/z [M + 
H]+ calcd for C11H11O4: 207.0652; found: 207.0646. 
 
5,8-Dihydroxy-4-methoxy-3,7-dimethylisochroman-1-one (34). Compound 28 (224 
mg, 0.71 mmol) was dissolved in methanol (10 mL) and sodium methoxide (192 mg, 3.55 mmol) 
was added. The reaction mixture was stirred at room temperature for 1 hour. Methanol was 
removed under reduced pressure. The crude residue was then diluted with ethyl acetate (10 mL) 
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and washed by hydrochloric acid (aqueous, 2 M) and brine and dried over sodium sulfate and 
concentrated. Purification by column chromatography on silica gel (hexane/ethyl acetate = 2:1 
(v/v)) gave the product 34 as solid (72.6 mg, mp:159-161 °C, 43%, rf = 0.3(hexane/ethyl acetate 
= 2:1 (v/v))). 1H NMR (400 MHz, CDCl3) δ = 10.89 (s, 1H), 6.95 (s, 1H), 6.10 (br, 1H), 4.93 
(qd, J=6.8, 3.8, 1H), 4.62 (d, J=3.8, 1H), 3.43 (s, 3H), 2.23 (s, 3H), 1.38 (d, J=6.8, 3H). 13C 
NMR (100 MHz, CDCl3){1H}: δ = 168.5, 154.8, 145.8, 128.9, 126.1, 117.2, 106.1, 78.2, 72.9, 
56.4, 18.0, 15.8. HRMS (ESI-TOF) m/z: [M - H]- Calcd for C12H13O5 237.0768; Found: 
237.0771. 
 
Methyl 2-(2,2-dimethoxyethylidene)-5-methylhexanoate (38). To a solution of proline 
(1.0 mmol, 115 mg) in dimethyl sulfoxide (3.3 mL), isovaleraldehyde (0.86 g, 10 mmol) was 
added. After 10 min, trimethyl phosphonoacetatemalonate 35 (1.82 g, 10 mmol) was slowly 
added and the reaction was stirred 24 hours at room temperature. The reaction mixture was 
diluted with ethyl acetate (30 mL) and washed with water (20 mL), sodium bicarbonate solution 
(saturated, 20 mL) and brine (20 mL). The organic layer was dried over sodium sulfate and 
concentrated. The residue was added to the suspension of palladium on carbon (10 wt %, 2.11 g, 
2 mmol) in ethanol (100 mL). The mixture was stirred for 5 hours at 50 °C (oil bath) under 
hydrogen atmosphere. After cooling down to room temperature, the mixture was filtrated 
through Celite and ethanol was removed under reduced pressure. To the residue dissolved in 
dichloromethane (13 mL), glyoxal dimethyl acetal (1.50 g, 14.3 mmol), tetrabutylammonium 
iodide (TBAI, 173 mg) and 33 % sodium hydroxide solution (13.00 g) were added. After 30 min 
of stirring at room temperature, the reaction mixture was extracted with dichloromethane (20 mL 
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x 3). The combined organic layers were dried over sodium sulfate and concentrated. Purification 
by column chromatography on silica gel (hexane/ethyl acetate = 5:1 (v/v)) gave the product 38 as 
liquid (82%, 1.88 g, Z/E = 1.0, rf = 0.4(hexane/ethyl acetate = 5:1 (v/v))). 1H NMR (400 MHz, 
CDCl3) δ = 6.56 (d, J=6.5, 1H), 5.73 (d, J=6.6, 1H), 5.36 (d, J=6.6, 1H), 5.07 (d, J=6.5, 1H), 
3.74 (s, 3H), 3.72 (s, 3H), 3.33 (s, 6H), 3.31 (s, 6H), 2.38 - 2.22 (m, 4H), 1.53 (dp, J=13.3, 6.6, 
2H), 1.35 - 1.24 (m, 4H), 0.89 (d, J=6.6, 6H), 0.86 (d, J=6.6, 6H). 13C NMR (100 MHz, 
CDCl3){1H}:δ = 168.0, 167.7, 137.1, 136.9, 136.0, 134.0, 99.9, 99.3, 53.3, 52.4, 51.9, 51.7, 38.2, 
37.4, 32.0, 28.2, 27.6, 25.5, 22.36, 22.35. HRMS (ESI-TOF) m/z: [M + H]+ Calcd for C12H23O4 
253.1410; Found: 253.1413. 
 
5-Hydroxy-3-isopentylfuran-2(5H)-one (39). Compound 38 (2.00 g, 8.7 mmol) was 
added to the mixture of hydrochloric acid (aqueous, 2 M, 20 mL) and tetrahydrofuran (20 mL). 
The reaction mixture was stirred at room temperature until the starting material was fully 
consumed. The reaction was extracted with ethyl acetate (30 mL x 2). The combined organic 
layers were dried over sodium sulfate and concentrated. Purification by column chromatography 
on silica gel (hexane/ethyl acetate = 3:1 (v/v)) gave the product 39 as liquid (1.32 g, 89%, rf = 
0.3(hexane/ethyl acetate = 2:1 (v/v))). 1H NMR (400 MHz, CDCl3) δ = 6.84 (q, J=1.6, 1H), 6.11 
(s, 1H), 5.06 (br, 1H), 2.47 - 2.15 (m, 2H), 1.66 - 1.52 (m, 1H), 1.47 - 1.38 (m, 2H), 0.90 (d, 
J=6.7, 6H). 13C NMR (100 MHz, CDCl3){1H}: δ = 172.9, 143.8, 143.8, 138.2, 97.3, 36.0, 27.6, 




3-Isopentyl-5-(phenylthio)furan-2(5H)-one (40). To a stirred solution of 5-hydroxy-3-
isopentylfuran-2(5H)-one 39 (1.70 g, 10 mmol) in toluene (100 mL) was added p-toluenesulfonic 
acid (PTSA, 57 mg, 0.3 mmol) followed by thiophenol (1.10 g, 10 mmol), and the mixture was 
heated at 80 oC (oil bath) for 15 hours. Toluene was removed under reduced pressure. The crude 
residue was then diluted with ethyl acetate (50 mL) and washed by water and brine and dried 
over sodium sulfate and concentrated. Purification by column chromatography on silica gel 
(hexane/ethyl acetate = 10:1 (v/v)) gave the product 3b as liquid (2.59 g, 99%, rf = 0.4 
(hexane/ethyl acetate = 10:1 (v/v))). 1H NMR (400 MHz, CDCl3) δ = 7.59 - 7.46 (m, 2H), 7.37 - 
7.30 (m, 3H), 6.88 (q, J=1.6, 1H), 6.10 (q, J=1.8, 1H), 2.19 - 2.11 (m, 2H), 1.41 (dt, J=13.3, 6.7, 
1H), 1.27 - 1.18 (m, 2H), 0.85 (d, J=2.0, 3H), 0.84 (d, J=2.0, 3H). 13C NMR (100 MHz, 
CDCl3){1H}: δ = 172.4, 144.0, 136.7, 134.4, 129.6, 129.1, 85.5, 36.2, 27.5, 23.0, 22.3, 22.2. 
HRMS (ESI-TOF) m/z: [M + H]+ Calcd for C15H19O2S 263.1100; Found: 263.1101. 
 
Methyl (E)-3-(3-pentyloxiran-2-yl)acrylate (42). Meta-Chloroperoxybenzoic acid 
(mCPBA, 4.63 g, 26 mmol) was added to a solution of compound 13 (1.82 g, 10 mmol) in 
dichloromethane (30 mL) at 0 °C (ice bath), and the mixture was stirred and warmed to room 
temperature. After 3 hours, the reaction was quenched with sodium thiosulfate solution and 
extracted with ethyl acetate. The organic layer was washed with sodium bicarbonate solution and 
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dried over sodium sulfate and concentrated. Purification by column chromatography on silica gel 
(hexane/ethyl acetate = 20:1 (v/v)) gave the product 5b as liquid (1.66 g, 84%). 1H NMR (400 
MHz, CDCl3) δ = 6.68 (ddd, J=15.7, 7.1, 1.0, 1H), 6.11 (dd, J=15.6, 1.0, 1H), 3.73 (s, 3H), 3.19 
(dd, J=7.1, 1.1, 1H), 2.87 (ddd, J=7.4, 4.2, 1.3, 1H), 1.68 - 1.55 (m, 2H), 1.50 - 1.40 (m, 2H), 
1.30 (m, 4H), 0.91 - 0.86 (t, J=7.2, 3H). 13C NMR (100 MHz, CDCl3){1H}: δ = 166.1, 145.2, 
123.0, 61.5, 56.3, 51.7, 31.9, 31.5, 25.5, 22.5, 13.9. HRMS (ESI-TOF) m/z: [M + H]+ Calcd for 
C11H19O3 199.1329; Found: 199.1325. 
 
5,8-Dihydroxy-7-isopentyl-4-methoxy-3-pentylisochroman-1-one (dihydro 
eurotiumide B). To a stirred solution of butanolide 40 (86.0 mg, 0.33 mmol) in tetrahydrofuran 
(3.0 mL) was added lithium tert-butoxide (1.0 M in tetrahydrofuran, 1.0 mL, 1.0 mmol) at -78 
°C (dry ice/acetone bath). And the mixture was stirred for 30 minutes at the same temperature. 
The epoxide 42 (84.8 mg, 0.4 mmol) in THF (1.0 mL) was added dropwise to the mixture and 
the mixture was stirred at -78 °C for 30 minutes. The mixture was warmed to room temperature 
and stirred 16 hours. Hydrochloric acid (aqueous, 2 M, 5 mL) was added to quench the reaction 
and the aqueous layer was extracted with ethyl acetate (5 mL x 2). The combined organic layers 
were dried over sodium sulfate and concentrated. The residue was dissolved in methanol (6 mL) 
and sodium methoxide (180 mg) was added. The reaction mixture was stirred at room 
temperature for 1 hour. Methanol was removed under reduced pressure. The crude residue was 
then diluted with ethyl acetate (10 mL) and washed by hydrochloric acid (aqueous, 2 M) and 
brine and dried over sodium sulfate and concentrated. Purification by column chromatography 
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on silica gel (hexane/ethyl acetate = 5:1 (v/v)) gave the product 1b as solid (47.2 mg, mp: 106-
108 °C, 41%, rf = 0.2(hexane/ethyl acetate = 5:1 (v/v))). 1H NMR (400 MHz, CDCl3) δ = 10.89 
(s, 1H), 6.95 (s, 1H), 4.78 (ddd, J=8.4, 4.9, 2.8, 1H), 4.66 (d, J=2.8, 1H), 3.40 (s, 3H), 2.73 - 2.48 
(m, 2H), 1.65 - 1.43 (m, 7H), 1.27 (td, J=6.6, 3.2, 4H), 0.94 (d, J=6.6, 6H), 0.89 - 0.83 (t, J=6.6, 
3H). 13C NMR (100 MHz, CDCl3){1H}: δ = 168.7, 154.4, 145.9, 133.7, 125.0, 117.4, 106.5, 
82.3, 70.9, 56.1, 38.3, 32.0, 31.3, 27.9, 27.5, 25.0, 22.5, 22.4, 13.9. HRMS (ESI-TOF) m/z: [M - 
H]- Calcd for C20H29O5 349.2020; Found: 349.2020. 
 
4,7-Dimethoxy-3-(phenylthio)isobenzofuran-1(3H)-one(46). To a solid of 2, 5-
dimethoxybenzoic acid 43 (50 mmol, 9.1 g) in round bottle flask was added thionyl chloride (50 
mL), and the mixture was refluxed for 16 hours. Thionyl chloride was removed under reduced 
pressure. The crude residue was added to a solution of dichloromethane (200 ml) and 
diethylamine (50 mL) at 0 °C (ice-water bath) and the mixture was stirred at room temperature 
for 16 hours. Water (100 mL) was added to quench the reaction, and the aqueous layer was 
extracted with dichloromethane (100 mL x 2). The combined organic layer was washed by water 
and brine, dried over sodium sulfate, and concentrated. Purification by column chromatography 
on silica gel gave the product 44 (10.4 g, yield = 88%). Then to a solution of 44 (6.0 g, 25 
mmoL) and tetramethylethylenediamine (TMEDA, 4.5 mL, 30 mmol) in tetrahydrofuran (50 
mL) was added sec-butyllithium (1.4 M, 21.4 mL, 30 mmoL) at -78 oC and the mixture was 
stirred at same temperature for 2 hours. Dimethylformamide (7.7 mL, 100 mmoL) was added to 
the mixture at -78 °C and the mixture was stirred for 30 minutes and then warm to room 
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temperature and stirred for another 16 hours. The reaction was quenched by hydrochloric acid 
(aqueous, 2 M, 20 mL) and the mixture was extracted with ethyl acetate (30 mL x 3). The 
combined extracts were dried over sodium sulfate and concentrated. The crude reside (45) was 
dissolved in acetic acid (100 mL) and hydrochloric acid (aqueous, 2 M, 100 mL). The resulting 
solution was refluxed (oil bath) for 16 h. After the reaction was complete, acetic acid was 
removed under vacuum and the residue was extracted with ethyl acetate (100 mL x 2). The 
combined organic layer was washed with water and brine, dried over sodium sulfate, and 
concentrated. To a stirred solution of the obtained crude aldehyde in toluene (250 mL) was added 
p-toluenesulfonic acid(PTSA, 143 mg, 0.75 mmol) followed by thiophenol (2.75 g, 25 mmol), 
and the mixture was heated at 80 °C (oil bath) for 15 hours. Toluene was removed under reduced 
pressure. The crude residue was then diluted with ethyl acetate (50 mL), washed with water and 
brine, dried over sodium sulfate, and concentrated. Purification by column chromatography on 
silica gel [hexane/ethyl acetate, 3:1 (v/v)] gave the product 46 (4.83 g, 64% yield). White solid; 
mp 113–115 °C; Rf = 0.25 [hexane/ethyl acetate, 3:1 (v/v)]. 1H NMR (600 MHz, DMSO-d6): δ = 
7.36 - 7.34 (m, 3 H), 7.32 - 7.28 (m, 3 H), 7.08 (d, J = 8.8 Hz, 1 H), 7.03 (s, 1 H), 3.92 (s, 3 H), 
3.78 (s, 3 H). 13C NMR (150 MHz, DMSO-d6): δ = 166.3, 151.8, 147.7, 134.9, 133.8, 130.1, 
129.5, 129.2, 119.7, 114.6, 113.9, 82.7, 56.8, 56.6. HRMS (ESI-TOF): m/z [M + H]+ calcd for 
C16H15O4S: 303.0686; found: 303.0689. 
 
Methyl (E)-1,4-dihydroxy-5,8-dimethoxy-3-(prop-1-en-1-yl)-2-naphthoate (47). To a 
stirred solution of 46 (302 mg, 1.0 mmol) in tetrahydrofuran (3.0 mL) was added lithium tert-
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butoxide (1.0 M in tetrahydrofuran, 3.0 mL, 3.0 mmol) at -78 °C (dry ice/acetone bath). The 
mixture was stirred for 30 min at the same temperature. The epoxide 27 (213.0 mg, 1.5 mmol) in 
tetrahydrofuran (1.0 mL) was added dropwise to the mixture, and the mixture was stirred at -78 
°C (dry ice/acetone bath) for 30 min. The mixture was then warmed to room temperature and 
stirred 16 hours. Hydrochloric acid (aqueous, 2 M, 10 mL) was added to quench the reaction, and 
the aqueous layer was extracted with ethyl acetate (10 mL × 2). The combined organic layers 
were dried over sodium sulfate and concentrated. Purification by column chromatography on 
silica gel (hexane/ethyl acetate, 3:1 (v/v)) gave the product 47 along with benzofuran 48. Light 
brown oil; 206.7 mg, yield = 50%, d.r. = 1/1. 1H NMR (600 MHz, CDCl3) δ = 12.62 (s, 1H), 
12.38 (s, 1H), 9.79 (s, 1H), 9.74 (s, 1H), 7.56 (dd, J=6.6, 2.9, 2H), 7.49 – 7.45 (m, 2H), 7.33 – 
7.31 (m, 3H), 7.19 (ddd, J=14.5, 7.8, 6.2, 3H), 6.97 (dd, J=11.3, 8.7, 2H), 6.81 (dd, J=19.8, 8.7, 
2H), 4.88 (tdd, J=8.9, 6.8, 4.3, 2H), 4.79 (dd, J=9.9, 1.7, 2H), 4.04 (s, 3H), 4.03 (s, 4H), 3.97 (s, 
3H), 3.95 (s, 3H), 1.65 (d, J=6.4, 3H), 1.32 (d, J=6.8, 3H). 13C NMR (150 MHz, CDCl3) δ = 
170.1, 168.7, 155.9, 155.8, 154.1, 154.0, 149.6, 149.5, 143.0, 141.0, 135.2, 134.7, 134.4, 133.6, 
133.0, 129.5, 129.3, 129.1, 128.7, 128.4, 128.0, 120.8, 120.6, 117.6, 117.2, 112.8, 110.1, 109.9, 
107.4, 107.0, 102.1, 101.8, 78.0, 77.7, 57.0, 57.0, 46.0, 44.4, 20.0, 18.7. HRMS (ESI-TOF): m/z 
[M + H]+ calcd for C22H21O6S: 413.1053; found: 413.1046. 
 
Naphtho[1,2-b]furan-4-carboxylic acid, 5-hydroxy-6,9-dimethoxy-2-methyl-, methyl 
ester (48). Yellow Solid; mp, 156-158 °C; 132.1 mg, yield = 42%. 1H NMR (600 MHz, CDCl3) 
δ = 12.53 (s, 1H), 7.04 (d, J=8.7, 1H), 6.87 (q, J=0.9, 1H), 6.84 (d, J=8.7, 1H), 4.08 (s, 3H), 4.07 
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(s, 3H), 4.04 (s, 3H), 2.60 (d, J=0.8, 3H). 13C NMR (150 MHz, CDCl3) δ = 171.2, 158.9, 155.6, 
153.0, 148.4, 142.5, 124.0, 118.5, 114.2, 110.2, 106.0, 104.7, 100.9, 57.1, 56.7, 52.1, 14.3. 
HRMS (ESI-TOF): m/z [M + H]+ calcd for C17H17O6: 317.1020; found: 317.1019. 
 
Methyl (E)-1,4-dihydroxy-5,8-dimethoxy-3-(prop-1-en-1-yl)-2-naphthoate (49). To a 
stirred solution of 46 (302 mg, 1.0 mmol) in tetrahydrofuran (3.0 mL) was added lithium tert-
butoxide (1.0 M in tetrahydrofuran, 3.0 mL, 3.0 mmol) at -78 °C (dry ice/acetone bath). The 
mixture was stirred for 30 min at the same temperature. Methyl sorbate (189.0 mg, 1.5 mmol) in 
tetrahydrofuran (1.0 mL) was added dropwise to the mixture, and the mixture was stirred at -78 
°C (dry ice/acetone bath) for 30 min. The mixture was then warmed to room temperature and 
stirred 16 hours. Hydrochloric acid (aqueous, 2 M, 10 mL) was added to quench the reaction, and 
the aqueous layer was extracted with ethyl acetate (10 mL x 2). The combined organic layers 
were dried over sodium sulfate and concentrated. Purification by column chromatography on 
silica gel (hexane/ethyl acetate = 5:1 (v/v)) gave the product 49 (rf = 0.10 (hexane/ethyl acetate = 
1:1 (v/v))). Yellow solid; mp, 109-111 °C; 257.6 mg, yield = 81%. 1H NMR (600 MHz, CDCl3) 
δ = 9.64 (s, 1 H), 9.40 (s, 1 H), 6.58 (dq, J =16.0, 1.7 Hz, 1 H), 6.55 (d, J = 8.3 Hz, 1 H), 6.50 (d, 
J = 8.5 Hz, 1 H), 6.24 (dq, J = 16.0, 6.6 Hz, 1 H), 3.94 (s, 3 H), 3.94 (s, 3 H), 3.91 (s, 3 H), 1.92 
(dd, J = 6.6, 1.8 Hz, 3 H). 13C NMR (150 MHz, CDCl3): δ = 169.1, 150.9, 150.5, 144.2, 143.6, 
130.5, 124.5, 118.2, 117.9, 116.4, 114.8, 105.1, 104.1, 56.5, 56.4, 52.3, 19.6. HRMS (ESI-TOF): 




(E)-4-(2,4-Dimethoxy-6-methylphenyl)but-3-en-2-one (52). Phosphoryl chloride (14.5 
mL, 0.156 mol) was added dropwise to a solution of 3,5-dimethoxytoluene (19 g, 0.12 mol) in 
dimethylformamide (100 mL) at 0 °C. The reaction was warmed to room temperature overnight. 
The reaction was quenched by slowly adding cold water (100 mL). The suspension was further 
diluted with water (200 mL) and saturated sodium bicarbonate solution (100 mL), stirred 
overnight.  The mixture was extracted with ethyl acetate (150 mL x 3). The combined organic 
layers were dried over sodium sulfate and concentrated to give 51 as a white powder (19.4 g, 
97%) for the next step. To a solution of 2,4-dimethoxy-6-methylbenzaldehyde 51 (9.00 g, 50 
mmol) and acetone (37 mL) in ethanol (88 mL) was added aqueous sodium hydroxide (1.25 M, 
176 mL). The mixture was stirred at room temperature for 2 hours and then the mixture was 
subsequently neutralized with hydrochloric acid (aqueous, 2.0 M) at 0 oC (ice bath).  Ethanol was 
evaporated under vacuum and the water phase was extracted with ethyl acetate (200 ml x 2). The 
combined organic phases were washed with brine, dried over MgSO4, filtered and evaporated in 
vacuo. The crude product was purified by chromatography on silica gel (hexane/ethyl acetate = 
5:1 (v/v)) to afford product 52 (10.0 g, 91%) as a yellow solid. 1H NMR (400 MHz, CDCl3) δ = 
7.75 (d, J=16.3, 1H), 6.89 (d, J=16.3, 1H), 6.38 (d, J=2.4, 1H), 6.34 (d, J=2.4, 1H), 3.86 (s, 3H), 
3.82 (s, 3H), 2.44 (s, 3H), 2.35 (s, 3H). 13C NMR (100 MHz, CDCl3){1H} δ = 199.9, 161.6, 
161.2, 141.8, 137.6, 128.9, 115.5, 108.0, 96.5, 55.6, 55.5, 27.7, 21.8. HRMS (ESI/QTOF) m/z: 





(57). To a solution of 52 (2.20 g, 10 mmol, 1.0 equiv) and triethylamine (2.10 mL, 1.5 equiv) in 
dichloromethane (40 mL) at 0 
oC (ice bath) was added dropwise tert-Butyldimethylsilyl 
trifluoromethanesulfonate (3.10 mL, 1.35 equiv). After stirring at room temperature for 2 hours, 
the solution was poured into saturated aqueous sodium bicarbonate and was extracted with 
dichloromethane (40 mL x 3). The organic layer was dried over sodium sulfate, filtered, and 
concentrated. The residue was purified by flash chromatography to afford the silyl enol ether as 
colorless liquid, which was directly used for the next step. The silyl enol ether and methyl 4,4-
diethoxybut-2-ynoate 54 (1.87 g, 1.0 equiv) were dissolved in toluene (10 mL) and the reaction 
mixture was heated at 170 °C (oil bath) for 40 hours in a sealed tube. After cooling to room 
temperature, the reaction mixture and 2,3-Dichloro-5,6-dicyano-1,4-benzoquinone (DDQ, 2.96 
g, 1.3 equiv) in toluene (20 mL) was added into a round bottom flask. The mixture was cooled to 
room temperature after heating at 80 °C (oil bath) for 2 hours and the reaction mixture was 
diluted with ethyl acetate (50 mL) and filtrated through Celite. The filtrate was then concentrated 
and the residue was run by flash column on silica gel (hexane/ethyl acetate = 3:1 (v/v)), which 
directly used for the next step. To the obtained product in tetrahydrofuran (20 mL) solution, 
tetra-n-butylammonium fluoride (TBAF, 1.0 M in tetrahydrofuran, 15 mL) was added dropwise. 
After stirring at room temperature for 15 hours, the reaction mixture was diluted with ethyl 
acetate (100 mL) and then washed by aqueous hydrochloric acid (2.0 M) and brine. The organic 
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layer was dried over MgSO4, filtered, and concentrated. The residue was purified by flash 
chromatography on silica gel (hexane/ethyl acetate = 2:1 (v/v)) to afford product 57 (2.08 g, 
63%) as a white solid. 1H NMR (400 MHz, CDCl3) δ = 9.97 (s, 1H), 7.25 (d, J=2.6, 1H), 6.85 (d, 
J=2.6, 1H), 6.38 (d, J=2.3, 1H), 6.34 (d, J=2.3, 1H), 3.81 (s, 3H), 3.63 (s, 3H), 3.58 (s, 3H), 1.99 
(s, 3H). 13C NMR (100 MHz, CDCl3){1H}  δ = 191.3, 168.7, 160.2, 157.8, 157.6, 140.0, 138.6, 
135.9, 127.8, 123.9, 120.1, 115.4, 106.4, 96.0, 55.8, 55.4, 52.5, 20.5. HRMS (ESI/QTOF) m/z: 
[M + H]+ Calcd for C18H19O6 331.1176, Found: 331.1183.  
 
Methyl 3-formyl-2',4',5-trimethoxy-6'-methyl-[1,1'-biphenyl]-2-carboxylate (58). To 
a cooled (0 °C, ice bath) stirred solution of 57 (2.08 g, 6.3 mmol, 1.0 equiv) in 
dimethylformamide (15 mL) were added potassium carbonate (3.48 g, 4.0 equiv) and methyl 
iodide (2.67 g, 3.0 equiv). After being stirred at room temperature for 15 hours, the mixture was 
diluted with water (20 mL) and extracted with ethyl acetate (60 mL x 3). The combined extracts 
were dried over sodium sulfate, filtered, and concentrated. The residue was purified by flash 
chromatography on silica gel (hexane/ethyl acetate = 2:1 (v/v)) to afford product 58 (2.06 g, 
95%) as solid. 1H NMR (400 MHz, CDCl3) δ = 10.10 (s, 1H), 7.40 (d, J=2.6, 1H), 6.95 (d, J=2.6, 
1H), 6.40 (d, J=2.3, 1H), 6.35 (d, J=2.3, 1H), 3.88 (s, 3H), 3.83 (s, 3H), 3.66 (s, 3H), 3.58 (s, 
3H), 2.02 (s, 3H). 13C NMR (100 MHz, CDCl3){1H} δ = 190.7, 167.8, 160.6, 160.2, 157.9, 
139.7, 138.5, 136.0, 128.7, 122.8, 120.4, 112.0, 106.2, 95.9, 55.8, 55.7, 55.3, 52.2, 20.5. HRMS 





carbonitrile (60). To a stirred solution of 58 (2.06 g, 6.0 mmol, 1.0 equiv) in dichloromethane 
(40 mL) at 0 °C (ice bath), was added trimethylsilyl cyanide (832 mg, 1.4 equiv), and a solution 
of potassium cyanide (10 mg, 0.02 equiv) and 18-crown-6 (34.1 mg, 0.02 equiv) in 
tetrahydrofuran (3.0 mL). The reaction mixture was stirred at the same temperature for 1.5 hours, 
and for 30 min at room temperature. The reaction mixture was then concentrated and the residue 
was dissolved in acetic acid (10 mL) and stirred at 40 °C (oil bath) for 40 hours. The reaction 
was neutralized by addition of saturated sodium bicarbonate solution until no any bubbles 
formed. The solution was extracted with ethyl acetate three times and the combined organic layer 
were washed with water and brine, dried over sodium sulfate, filtered, and concentrated. The 
residue was purified by flash chromatography on silica gel (hexane/ethyl acetate = 2:1 (v/v)) to 
afford product 60 (1.58 g, 78%, dr = 1:1) as a white solid. 1H NMR (400 MHz, CDCl3) δ = 7.05 
(d, J=1.4, 1H), 6.94 (d, J=2.1, 1H), 6.48 – 6.42 (m, 1H), 6.40 (dd, J=6.1, 2.2, 1H), 5.96 (s, 1H), 
3.94 (s, 3H), 3.84 (s, 3H), 3.69-3.64 (s, 3H), 2.07-2.02 (s, 3H). 13C NMR (100 MHz, 
CDCl3){1H} δ = 166.0, 165.3, 160.8, 158.0, 145.0, 140.8, 137.8, 121.4, 117.0, 115.2, 114.6, 
106.7, 105.5, 96.2, 64.4, 56.3, 55.8, 55.4, 20.5. HRMS (ESI/QTOF) m/z: [M + H]+ Calcd for 





5,6,11(12H)-trione (63). To a round bottom flask was charged with cyanophthalide 40 (33.9 mg, 
0.1 mmol, 1.0 equiv) and enone 61 (25.5 mg, 1.1 equiv). Degassed dry tetrahydrofuran (2 mL) 
was then introduced and the resultant solution then cooled to -78 °C (dry ice/acetone bath). 
Lithium tert-butoxide (1.0 M in tetrahydrofuran, 0.3 mL, 3.0 equiv) was then added dropwise via 
syringe to the stirred reaction mixture. The resulting yellow solution was stirred at -78 °C (dry 
ice/acetone bath) for 45 min and then at room temperature for 2 hours. Saturated ammonium 
chloride solution (5 mL) was added to quench the reaction under argon. The aqueous layer was 
separated and extracted with ethyl acetate (5 mL x 3). The combined organic layers were washed 
with water and brine, dried over sodium, filtered, and concentrated.  The crude residue was 
dissolved in ethyl acetate (5 mL) and 2,3-dichloro-5,6-dicyano-1,4-benzoquinone (DDQ, 30 mg, 
1.3 equiv) was added in one portion. After stirring at room temperature for 2 hours, the reaction 
mixture was diluted by ethyl acetate (15 mL) and then washed by saturate sodium bicarbonate 
solution (15 mL x 2) and brine, dried over sodium sulfate, filtered, and concentrated. The residue 
was purified by flash chromatography on silica gel (hexane/ethyl acetate = 1:1 (v/v)) to afford 
product 63 (40.0 mg, 74%) as orange solid. 1H NMR (400 MHz, CDCl3) δ = 7.57 (d, J=1.4, 1H), 
6.96 (d, J=1.4, 1H), 6.65 (s, 1H), 6.45 – 6.34 (m, 3H), 3.93 (s, 3H), 3.89 (s, 3H), 3.85 (s, 3H), 
3.84 (s, 3H), 3.67 (s, 3H), 2.02 (s, 3H), 1.84 (s, 3H), 1.80 (s, 3H). 13C NMR (100 MHz, 
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CDCl3){1H} δ = 186.2, 182.0 181.2, 164.3, 162.6, 161.5, 159.9, 157.2, 155.2, 150.0, 140.7, 
139.1, 136.8, 136.1, 125.1, 124.5, 121.6, 116.1, 109.8, 106.8, 102.5, 96.9, 96.5, 56.1, 56.0, 55.9, 
55.5, 55.3, 39.1, 29.4, 29.4, 20.7. HRMS (ESI/QTOF) m/z: [M + H]+ Calcd for C32H31O8 
543.2013, Found: 543.2013.   
 
7-(2,4-Dimethoxy-6-methylphenyl)-2,4-dihydroxy-9-methoxy-12,12-
dimethyltetracene-5,6,11(12H)-trione (naphthacemycin A9). To a round bottom flask was 
charged with cyanophthalide 60 (33.9 mg, 0.1 mmol, 1.0 equiv) and enone 65 (42.3 mg, 1.1 
equiv). Degassed dry tetrahydrofuran (2 mL) was then introduced and the resultant solution then 
cooled to -78 °C (dry ice/acetone bath). Lithium tert-butoxide (1.0 M in tetrahydrofuran, 0.3 mL, 
3.0 equiv) was then added dropwise via syringe to the stirred reaction mixture. The resulting 
yellow solution was stirred at -78 °C (dry ice/acetone bath) for 45 min and then at room 
temperature for 2 hours. Saturated ammonium chloride solution (5 mL) was added to quench the 
reaction under argon. The aqueous layer was separated and extracted with ethyl acetate (5 mL x 
3). The combined organic layers were washed with water and brine, dried over sodium sulfate, 
filtered, and concentrated. The crude residue was dissolved in ethyl acetate (5 mL) and 10% wt 
palladium/carbon (40 mg) were added, and then stirred vigorously at room temperature under 
hydrogen atmosphere(1 atm) for 15 h. The reaction mixture was diluted with ethyl acetate (15 
mL) and filtrated through Celite. The filtrate was concentrated and the crude residue was 
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dissolved in ethyl acetate (5 mL) and 2,3-dichloro-5,6-dicyano-1,4-benzoquinone (DDQ, 30 mg, 
1.3 equiv) was added in one portion. After stirring at room temperature for 2 hours, the reaction 
mixture was diluted by ethyl acetate (15 mL) and then washed by saturated sodium bicarbonate 
solution (15 mL x 2) and brine, dried over sodium sulfate, filtered, and concentrated. The residue 
was purified by flash chromatography on silica gel (hexane/ethyl acetate = 1:1 (v/v)) to afford 
product 3 (35.0 mg, 68%) as orange solid. 1H NMR (400 MHz, CDCl3) δ = 12.86 (s, 1H), 7.52 
(d, J=2.7, 1H), 6.99 (d, J=2.6, 1H), 6.54 (s, 1H), 6.43 (s, 1H), 6.38 (s, 1H), 6.21 (d, J=1.7, 1H), 
3.94 (s, 3H), 3.78 (s, 3H), 3.65 (s, 3H), 2.06 (s, 3H), 1.82 (s, 3H), 1.76 (s, 3H). 13C NMR (100 
MHz, CDCl3){1H} δ = 185.9, 185.2, 182.8, 165.1, 163.8, 162.8, 160.0, 156.8, 155.6, 154.8, 
140.3, 137.1, 135.9, 135.7, 125.9, 124.8, 121.0, 110.3, 109.7, 107.0, 105.6, 101.7, 96.5, 56.0, 
55.9, 55.3, 39.4, 30.2, 29.7, 20.8. HRMS (ESI/QTOF) m/z: [M + H]+ Calcd for C30H27O8 
515.1700, Found: 515.1705. 
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CHAPTER 2.    SYNTHESIS OF BIOBASED COMPOUNDS  
2.1       Introduction 
According to the USDA (United States Department of Agriculture), biobased products 
are “derived from plants and other renewable agricultural, marine and forestry materials. 
Biobased products generally provide an alternative to conventional petroleum-derived products 
and include a diverse range of offerings such as lubricants, detergents, inks, fertilizers, and 
bioplastics.” Even though biofuels, like bioethanol and biodiesel, are a major sector of the 
biobased industry, researchers and firms now also focus on developing biobased compounds 
from biomass that nearly every industry depends on.1 Figure 2.1 shows some commercially 
available biobased compounds. The biobased compounds are eco-friendly as they neither release 
toxic emissions nor cause pollution.2 The biobased compounds market expects to reach around 
97.2 billion dollars by the end of 2023. 
 
Figure 2.1    Biobased compounds. 
Pyrones are a family of six-membered unsaturated cyclic compounds with an oxygen 
atom in the ring. There are two different pyrone isomers, 2-pyrone and 4-pyrone, depending on 




            Figure 2.2    Structure of pyrones. 
The 2-pyrone unit is abundant in numerous natural products isolated from plants, 
animals, marine organisms, bacteria, fungi, and insects that exhibit a broad range of biological 
activities (Figure 2.3).4 The simplest example, 2-pyrone, is a versatile building block and used in 
organic synthesis to generate more complex chemical structures because it may participate in 
various cycloaddition reactions to form bicyclic lactones.  
 
Figure 2.3    Bioactive pyrone natural products. 
2.1.1    Methyl coumalate 
Malic acid occurs naturally in all fruits and many vegetables and is generated during 
metabolism. It contributes to the sourness in many fruits, like apples and grapes. When malic 
acid was treated with fuming sulfuric acid, coumalic acid, a 2-pyrone, was formed through a self-




Scheme 2.1    Synthesis of coumalic acid from malic acid. 
The mechanism of the transformation was also proposed (Scheme 2.2). The reaction 
proceeds via an acid-catalyzed dehydration/decarbonylation of malic acid to give an initial 
aldehyde acid enol, which condenses by Michael addition of the enol to the enone, followed by 
lactonization and dehydration to give the desired coumalic acid. Overall, two moles of malic acid 
condense to give one mole of coumalic acid with the loss of two moles of carbon monoxide and 
four equivalents of water. 
 
Scheme 2.2    Mechanism of coumalic acid formation. 
Methyl coumalate, formed through the esterification of coumalic acid with methanol, is 
an electron-deficient pyrone. It reacts with various electron-rich dienophiles in an inverse 
electron-demand Diels–Alder type reaction. As a team in the Center for Biorenewable Chemicals 




In 2011, the Kraus group reported the formation of para-substituted alkyl benzoates from 
unactivated alkenes and methyl coumalate.6 The reaction proceeds with excellent regioselectivity 
during the Diels-Alder reaction. Later, the Diels-Alder reaction of methyl coumalate with 
alkenes bearing electron-withdrawing groups was discovered.7 The reaction provides 
terephthalates or isophthalates. Then, the Kraus group accomplished the Diels-Alder reactions 
between methyl coumalate and vinyl ethers, ketals or orthoesters.8-9 They synthesized substituted 
benzoates. Recently, the Kraus group reported the Diels-Alder reaction of methyl coumlate with 
acyclic enamines,10 3‑chloroindoles11 and hydroxyquinones12. (Scheme 2.3). 
 





2.1.2    Dehydroacetic acid 
Dehydroacetic acid is a pyrone derivate (Figure 2.5). It is isolated from Solandra nitida, a 
flowering plant.13 Dehydroacetic acid is used as a fungicide and bactericide. It is found in 
synthetic resins as a plasticizer and in toothpastes as an antienzyme agent. It also works as a food 
preservative to prevent pickle bloating in squash and strawberries. Because of diverse 
applications in industry, the reactivities of dehydroacetic acid were widely explored and a variety 
of dehydroacetic acid derivatives were synthesized. 
Scheme 2.4 shows some transformation of dehydroacetic acid. Alkylation, bromination, 
reactions with primary amines and condensation with aldehydes were all reported.13 However, 
aldol reactions via the dianion of dehydroacetic acid have not been reported.  
 





2.2       Result and Discussion 
2.2.1    Synthesis of isophthalates from methyl coumalate. 
Benzoic acid and isophthalic acid are prepared as commodity chemicals by the benzylic 
oxidation of toluene or xylene using a cobalt or manganese catalyst (Scheme 2.5).14 As a team in 
the Center for Biorenewable Chemicals (CBiRC), we have extensively researched the reactivity 
of methyl coumalate. We recently reported the synthesis of para-substituted benzoic acids by the 
reaction of methyl coumalate with alkenes.6 The mechanism involves an in-situ generated 
bicyclic lactone which loses carbon dioxide and undergoes dehydrogenation providing the 
aromatic ester, as illustrated in Scheme 2.6. 
 
Scheme 2.5    Synthesis of isophthalic acids. 
 
Scheme 2.6    The reaction of methyl coumalate with alkenes. 
We envisioned that bicyclic lactones from methyl coumalate and enol ethers could offer 
64 
 
an opportunity to open the lactone under basic or acidic conditions. The following elimination 
reactions will produce isophthalates (Scheme 2.7). This strategy utilizes all of the carbons of 
methyl coumalate, increasing the atom economy of the transformation.  
 
Scheme 2.7    Envisioned synthesis of isophthalates from methyl coumalate. 
The cycloaddition of methyl coumalate with butyl vinyl ether worked well in acetonitrile 
at 80 °C. The formed bicyclic lactone was explored in a number of acids and bases to determine 
the optimal conditions for isophthalates formation. The result was shown in Table 2.1. Our best 
conditions involved five percent of PTSA (p-toluenesulfonic acid) in boiling methanol.  
 
Entry Cat (5 mol%) T (oC) Yield (%) 
1 H2SO4 65 48 
2 CF3COOH 65 29 
3 PTSA 65 82 
4 NaOH 65 43 
5 K2CO3 65 57 
6 NaOMe 65 65 
7 PTSA 45 47 
Table 2.1    Optimization of the aromatization reaction. 
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Examples are illustrated below in Scheme 2.8.  The yields over the two-step sequence are 
very good.  Aromatization with PTSA in methanol gives good yields of isophthalates.  In the 
case of 3a, butyl methyl isophthalate was formed in 15% yield. Methyl and phenyl substituted 
isophthalates 3b-3c were synthesized. We got hydroxyl substituted isophthalate 3d. Cyclic 
isophthalate 3e were obtained. Heterocyclic systems also participate effectively in this 
transformation. The preparation of a thiophene substituted isophthalate 3f was achieved in very 
good overall yield. 
The corresponding enol silyl ethers also formed stable adducts with methyl coumalate. 
However, the adducts do not undergo high-yield aromatization to afford the isophthalates. As 
shown below in Scheme 2.9, the adduct from the reaction of methyl coumalate with the enol silyl 
ether of cyclopentanone 4 afforded two main products. Apparently, rapid removal of the silyl 
ether group in methanol yields an alcohol 6 that undergoes some fragmentation in addition to 
aromatization.   
  The adduct of the enol silyl ether of acetophenone 7 reacted with PTSA in methanol to 
afford a product in 90% yield that was clearly not an isophthalate.  After examination of the 
NMR, IR and mass spectrum, we assigned the structure to be pyrone 8 shown in Scheme 2.10.  
The mechanism of formation is not clear, but likely involves a retro-aldol reaction and an 




Scheme 2.8.  Isophthalates from lactone intermediates. 
 




Scheme 2.10.  Rearrangement of silyloxy lactone. 
The two-step Diels-Alder/aromatization pathway to substituted isophthalates proceeds in 
high overall yields and is operationally convenient.  A variety of alkyl, aryl and heteroaryl 
isophthalates can be prepared.  Adducts of alkyl vinyl ethers afford higher yields of isophthalates 
than adducts of enol silyl ethers.   
2.2.2    The dianion of dehydroacetic acid: A direct synthesis of pogopyrone A 
When we attempted to deprotonate dehydroacetic acid 9 using two equivalents of lithium 
diisopropylamide, followed by the addition of benzaldehyde, we obtained the expected aldol 
product 11 in only 27% yield. The majority of the material was starting material. Potassium tert-
butoxide gave no reactions (Scheme 2.11).  Reasoning that the corresponding silyl enol ether 10 
might be more reactive, we reacted dehydroacetic acid 9 with dichlorodimethylsilane and 
triethylamine in dichloromethane at room temperature. This process afforded the silane 10 in 
99% yield (Figure 2.4). 
Compound 10, which could be generated in situ, reacted readily with a number of 
aldehydes and N-bromosuccinimide.15 Boron trifluoride etherate was an effective Lewis acid 
catalyst for the aldol reaction. The products and yields are listed in Scheme 2.12. 
 




Scheme 2.11    Synthesis of 11a. 
 
Scheme 2.12    Addition reactions via silyl enol ether 10. 
Although 10 made possible the synthesis of compounds on millimole scales, its tendency 
to decompose during storage prompted us to evaluate other dianion equivalents. Although the 
boron or tin enolate was unreactive, the titanium enolate, generated via titanium tetrachloride and 
N,N-diisopropylethylamine in dichloromethane, afforded an 80% yield of the aldol product 11a 
with benzaldehyde. Workup conditions at low temperature were essential to minimize 
dehydration. The products and yields are shown in Scheme 2.13. This chemistry was scalable 
and 11b was synthesized on a 50 mmol scale. 
Pogopyrone A is a compound isolated from Pogostemon heynianus Benth Syn.16 
Oxidation of 11a with DMP (Dess–Martin periodinane, an oxidation reagent) afforded a 78% 
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yield of pogopyrone A(enol/keto = 4:1) (Scheme 2.14). 
 
Scheme 2.13    Addition reactions via titanium enolate. 
 
Scheme 2.14    Synthesis of pogopyrone A. 
Selective reactions at the acetyl group of dehydroacetic acid have been achieved via 
either silyl enol ether 10 or the titanium enolate of 9. The titanium chemistry can be scaled to 
make 11b on a 50 mmol scale. A direct synthesis of pogopyrone A was achieved. 
2.3          Conclusion 
   A variety of biobased compounds were synthesized from methyl coumalate and 
dehydroacetic acid. The Diels-Alder reaction of methyl coumalate with vinyl ethers afforded 
stable bicyclic lactones. Substituted isophthalates were synthesized by the treatment of bicyclic 
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lactones with acids in methanol. A variety of alkyl, aryl and heteroaryl isophthalates can be 
prepared in high overall yields. The two-step Diels–Alder/aromatization pathway to substituted 
isophthalates utilized all of the carbons of methyl coumalte and increased the atom economy of 
the transformation. 
Selective aldol reactions at the acetyl group of dehydroacetic acid have been achieved via 
the either silyl enol ether or the titanium enolate. Boron trifluoride etherate was needed in the 
transformations via the silyl enol ether. The titanium enolate reacted effectively with various 
aldehydes. The yields range from 50-80%. Titanium chemistry can be scaled to a 50 mmol scale 
when isobutyraldehyde was used in the aldol reaction. Oxidation of the adduct with 
benzaldehyde by using the Dess-Martin periodinane afforded pogopyrone A in excellent overall 
yield.  
2.4.      Experimental 
General Information 
All starting materials were purchased from Sigma-Aldrich, Ambeed, Alfa Aesar, TCI and 
Oakwood Chemical. Solvents were all purchased from Sigma-Aldrich and Fisher Scientific and 
were used as received with the following exceptions. Tetrahydrofuran was distilled from lithium 
aluminum hydride. All reactions were monitored by thin layer chromatography (TLC) and 1H 
NMR. All yields refer to separated yield after column chromatography unless indicated. TLC 
was obtained by silica plate using UV light as a visualizing agent or Potassium permanganate 
solution with heat. All columns were performed with silica gel 60Å, particle size 40-63 μm. 1H 
and 13C NMR spectra were acquired in CDCl3 or other deuterated solvents on a Varian MR-400 
or Bruker Avance III 600 MHz spectrometer. Chemical shifts were reported in parts per million 
from the solvent resonance as the internal standard (CDCl3: δH = 7.26 ppm, δC = 77.16 ppm; 
DMSO-d6: δH = 2.50 ppm, δC = 39.52 ppm; Acetone-d6: δH = 2.05 ppm, δC = 29.84 ppm; 
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multiplicity was indicated as follows: s (singlet), d (doublet), t (triplet), q (quartet), p (pentet) and 
m (multiplet)). High-resolution mass spectra (HRMS) were recorded on an Agilent 6540 QTOF 
(quadrupole time of flight) mass spectrometer using ESI (electrospray ionization). Melting points 
were obtained on a Digimelt MPA160 instrument. 
General procedure for D-A reaction of methyl coumalate with enol ethers.  
Methyl coumalate (154 mg, 1.0 mmol, 1.0 equiv), enol ether (3.0 mmol, 3.0 equiv) and 
acetonitrile (1.0 mL) were added to a 15 mL sealed tube. The tube was heated in a 75 °C (oil 
bath) and stirred for 24 hours. After the reaction, the solvent was removed under reduced 
pressure and the residue was purified by silica gel chromatography. 
 
Methyl -8-butoxy-3-oxo-2-oxabicyclo[2.2.2]oct-5-ene-6-carboxyl-ate (2a). Colorless 
oil; 249 mg, yield = 98%. 1H NMR (400 MHz, CDCl3) δ = 7.20 - 7.17 (m, 1H), 5.68 - 5.65 (m, 
1H), 4.09 (m, 1H), 4.06 - 4.01 (m, 1H), 3.79 (s, 3H), 3.43 (ddd, J=8.3, 5.4, 1.8, 1H), 3.35 (ddd, 
J=9.0, 5.4, 1.8, 1H), 2.60 (dddd, J=13.3, 7.8, 3.8, 1.5, 1H), 1.59 (d, J=1.9, 1H), 1.46 (pd, J=6.8, 
3.8, 2H), 1.28 (tdd, J=14.6, 7.3, 1.6, 2H), 0.87 (td, J=7.3, 1.6, 3H). 13C NMR (100 MHz, CDCl3) 
δ = 170.75, 162.64, 138.43, 135.78, 73.41, 71.44, 69.33, 52.30, 47.63, 34.93, 31.64, 19.28, 
13.87. HRMS (ESI-QTOF) calcd for [M + H+]: 255.1227, found: 255.1226. 
 
Methyl -8-methoxy-8-methyl-3-oxo-2-oxabicyclo[2.2.2]oct-5-ene-6-carboxylate (2b). 
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Colorless oil; 140 mg, yield = 62%. 1H NMR (400 MHz, CDCl3) δ = 7.22 (dd, J=6.2, 2.1, 1H), 
5.60 (m, 1H), 3.81 (d, J=6.1, 1H), 3.76 (s, 3H), 3.10 (s, 3H), 2.15 (dd, J=14.0, 3.6, 1H), 1.84 (dd, 
J=14.2, 1.8, 1H), 1.42 (s, 3H). 13C NMR (100 MHz, CDCl3) δ = 171.19, 162.70, 139.57, 135.00, 
75.66, 73.58, 52.95, 52.21, 50.19, 40.90, 23.97. HRMS (ESI-QTOF) calcd for [M + H+]: 
227.0914, found: 227.0911. 
 
Methyl-8-methoxy-3-oxo-8-phenyl-2-oxabicyclo[2.2.2]oct-5-ene-6-carboxylate (2c). 
White solid; 250 mg, yield = 87%. 1H NMR (400 MHz, CDCl3) δ = 7.45 - 7.30 (m, 3H), 7.24 (m, 
2H), 7.16 (m, 1H), 5.78 (m, 1H), 4.24 (d, J=6.5, 1H), 3.76 (s, 3H), 3.03 (s, 3H), 2.77 (dd, J=14.2, 
4.1, 1H), 2.31 (d, J=14.3, 1H). 13C NMR (100 MHz, CDCl3) δ = 170.22, 162.52, 140.17, 138.09, 
137.68, 129.02, 128.62, 126.90, 81.19, 73.82, 52.43, 52.20, 51.44, 39.70. HRMS (ESI-QTOF) 
calcd for [M + H+]: 289.1071, found: 289.1076. 
 
Methyl-8-oxo-2,3,3a,4,7,7a-hexahydro-4,7-(epoxymethano) benzo furan-5-
carboxylate (2d). White solid; 208 mg, yield = 93%. 1H NMR (400 MHz, CDCl3) δ = 7.21 (dd, 
J=6.7, 2.0, 1H), 5.52 (m, 1H), 4.30 (dd, J=8.7, 3.5, 1H), 4.11 (tdd, J=8.6, 4.1, 1.9, 1H), 3.92 (ddt, 
J=7.1, 3.6, 1.7, 1H), 3.87 - 3.80 (m, 1H), 3.79 (s, 3H), 2.66 (dddd, J=9.3, 7.9, 6.3, 1.6, 1H), 2.23 
- 2.00 (m, 1H). 13C NMR (100 MHz, CDCl3) δ = 169.98, 162.52, 139.14, 138.27, 77.90, 76.50, 






5-carboxylate (2e). White solid; 242 mg, yield = 96%. 1H NMR (400 MHz, CDCl3) δ = 7.23 (m, 
1H), 5.46 (m, 1H), 3.99 (d, J=6.1, 1H), 3.79 (s, 3H), 3.17 (s, 3H), 2.16 (td, J=7.7, 6.7, 1.7, 1H), 
2.05 (dq, J=9.3, 4.7, 3.5, 2H), 1.79 (dtd, J=11.7, 6.2, 3.5, 2H), 1.72 - 1.60 (m, 1H), 1.53 (ddd, 
J=13.8, 8.8, 6.8, 1H). 13C NMR (100 MHz, CDCl3) δ = 171.31, 162.93, 139.56, 136.62, 88.78, 
77.21, 52.33, 52.16, 51.28, 50.90, 33.05, 27.66, 27.20. HRMS (ESI-QTOF) calcd for [M + H+]: 
253.1071, found: 253.1068. 
 
Methyl 8-methoxy-3-oxo-8-(thiophen-2-yl)-2-oxabicyclo[2.2.2]oct-5-ene-6-
carboxylate (2f). Oil; 263 mg, yield = 90%. 1H NMR (400 MHz, CDCl3) δ = 7.30 (dd, J=5.1, 
1.2, 1H), 7.09 (dd, J=6.6, 2.3, 1H), 6.91 (dd, J=5.1, 3.6, 1H), 6.86 (dd, J=3.6, 1.2, 1H), 5.80 - 
5.68 (m, 1H), 4.18 (d, J=6.6, 1H), 3.73 (s, 3H), 3.07 (s, 3H), 2.72 (dd, J=14.2, 4.0, 1H), 2.27 (dd, 
J=14.2, 1.6, 1H). 13C NMR (100 MHz, CDCl3) δ = 169.43, 162.36, 144.83, 138.15, 137.14, 
126.92, 126.79, 126.41, 78.79, 73.59, 53.99, 52.40, 51.40, 39.36. HRMS (ESI-QTOF) calcd for 




    Methyl-8-oxo-7a-((trimethylsilyl)oxy)-2,3,3a,4,7,7a-hexahydro-1H-4,7-
(epoxymethano)indene-5-carboxylate (4). White solid; 294 mg, yield = 95%. 1H NMR (400 
MHz, CDCl3) δ = 7.22 (dd, J=5.0, 0.9, 1H), 5.43 - 5.41 (m, 1H), 3.80 (s, 3H), 3.78 (d, J=6.3, 
1H), 2.17 (dd, J=8.8, 6.6, 1H), 2.11 - 2.01 (m, 1H), 1.98 - 1.88 (m, 1H), 1.86 - 1.68 (m, 3H), 1.61 
(m, 1H), 0.09 (s, 9H). 13C NMR (100 MHz, CDCl3) δ = 171.43, 163.04, 140.94, 136.12, 85.74, 
77.44, 55.75, 53.24, 52.34, 39.70, 27.95, 27.05, 2.05. HRMS (ESI-QTOF) calcd for [M + H+]: 
311.1309, found: 311.1316. 
 
Methyl-3-oxo-8-phenyl-8-((trimethylsilyl)oxy)-2-oxabicyclo[2.2.2] oct-5-ene-6-
carboxylate (7). White solid; 290 mg, yield = 84%. 1H NMR (400 MHz, CDCl3) δ = 7.50 - 7.43 
(m, 2H), 7.35 (m, 3H), 7.31 - 7.25 (m, 1H), 5.80 (m,1H), 3.96 (dd, J=6.4, 0.7, 1H), 3.84 (s, 3H), 
3.02 (d, J=3.8, 1H), 2.33 - 2.19 (m, 1H), -0.08 (s, 9H). 13C NMR (100 MHz, CDCl3) δ = 170.34, 
162.93, 144.06, 141.38, 135.43, 128.64, 128.28, 125.82, 77.37, 73.57, 57.73, 52.41, 43.30, 1.64. 
HRMS (ESI-QTOF) calcd for [M + H+]: 347.1309, found: 347.1312. 
General procedure for the formation of Isophthalates.  
A solution of 0.2 mmol of bicyclic adducts (2a to 2f, 4, 7) of methyl coumalate with 
vinyl ethers, one crystal of p-toluenesulfonic acid (PTSA) and 1.0 mL of methanol was boiled 
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for 18 hours. The solvent was removed under reduced pressure and the residue was purified by 
silica gel chromatography.   
 
  Dimethyl isophthalate (3a). White solid; 37.5 mg, yield = 82%. 1H NMR (400 MHz, 
CDCl3) δ = 8.68 (q, J=1.6, 1H), 8.22 (dt, J=7.8, 1.5, 2H), 7.54 - 7.47 (m, 1H), 3.94 (s, 6H). 
13C 
NMR (100 MHz, CDCl3) δ = 166.38, 133.94, 130.84, 130.70, 128.76, 52.52. HRMS (ESI-
QTOF) calcd for [M + H+]: 195.0652, found: 195.0650. 
 
Dimethyl 4-methylisophthalate (3b). White solid; 36.2 mg, yield = 88%. 1H NMR (400 
MHz, CDCl3) δ = 8.55 (d, J=1.9, 1H), 8.02 (dd, J=8.1, 1.8, 1H), 7.30 (d, J=8.0, 1H), 3.91 (s, 
3H), 3.90 (s, 3H), 2.64 (s, 3H). 13C NMR (100 MHz, CDCl3) δ = 167.26, 166.42, 145.68, 132.73, 
132.07, 131.99, 129.84, 128.06, 52.31, 52.15, 22.00. HRMS (ESI-QTOF) calcd for [M + H+]: 
209.0808, found: 209.0808. 
 
Dimethyl [1,1'-biphenyl]-2,4-dicarboxylate (3c). White solid; 46.9 mg, yield = 87%. 1H 
NMR (400 MHz, CDCl3) δ = 8.49 (d, J=1.8, 1H), 8.17 (dd, J=8.0, 1.8, 1H), 7.46 (d, J=8.0, 1H), 
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7.42 – 7.36 (m, 3H), 7.34 – 7.25 (m, 2H), 3.95 (s, 3H), 3.67 (s, 3H). 13C NMR (100 MHz, 
CDCl3) δ = 168.29, 166.16, 146.84, 140.27, 132.12, 131.18, 131.07, 129.14, 128.27, 128.22, 
127.96, 52.46, 52.29. HRMS (ESI-QTOF) calcd for [M + H+]: 271.0965, found: 271.0967. 
 
Dimethyl 5-(2-hydroxyethyl)isophthalate (3d). White solid; 43.4 mg, yield = 92%. 1H 
NMR (400 MHz, CDCl3) δ = 8.50 (q, J=1.5, 1H), 8.08 (t, J=1.3, 2H), 3.91 (s, 6H), 3.90 (t, J=6.5, 
2H), 2.95 (t, J=6.5, 2H), 1.93 (s, 1H). 13C NMR (100 MHz, CDCl3) δ = 166.41, 139.95, 134.50, 
130.78, 128.93, 63.15, 52.49, 38.74. HRMS (ESI-QTOF) calcd for [M + H+]: 239.0914, found: 
239.0912. 
 
Dimethyl 2,3-dihydro-1H-indene-4,6-dicarboxylate (3e). White solid; 21.7 mg, yield = 
47%. 1H NMR (400 MHz, CDCl3) δ = 8.52 - 8.37 (m, 1H), 8.03 (t, J=1.4, 1H), 3.91 (s, 3H), 3.91 
(s, 3H), 3.31 (t, J=7.6, 2H), 2.96 (t, J=7.6, 2H), 2.12 (p, J=7.4, 2H). 13C NMR (100 MHz, 
CDCl3) δ = 166.93, 166.82, 152.32, 146.65, 129.89, 129.26, 128.66, 126.62, 52.37, 52.14, 34.20, 





Dimethyl 4-(thiophen-2-yl)isophthalate (3f). White solid; 43.6 mg, yield = 83%. 1H 
NMR (400 MHz, CDCl3) δ = 8.36 (t, J=2.3, 1H), 8.22 - 8.01 (m, 1H), 7.56 (dd, J=8.1, 2.3, 1H), 
7.46 - 7.34 (m, 1H), 7.20 - 6.92 (m, 2H), 3.94 (s, 3H), 3.78 (s, 3H). 13C NMR (100 MHz, CDCl3) 
δ = 168.52, 166.01, 140.87, 138.43, 131.92, 131.84, 131.31, 130.87, 129.37, 127.67, 127.26, 
127.14, 52.67, 52.58. HRMS (ESI-QTOF) calcd for [M + H+]: 277.0529, found: 277.0526. 
 
Methyl (E)-2-oxo-6-styryl-2H-pyran-5-carboxylate (8). Yellow solid; 46.0 mg, yield = 
90%. 1H NMR (400 MHz, CDCl3) δ = 7.88 - 7.84 (m, 2H), 7.59 (d, J=7.3, 1H), 7.48 (d, J=15.8, 
1H), 7.47 (m, 3H), 7.08 (d, J=15.8, 1H), 6.79 (d, J=7.2, 1H), 3.80 (s, 3H). 13C NMR (100 MHz, 
CDCl3) δ = 167.84, 161.55, 159.80, 144.94, 138.51, 131.65, 130.77, 129.22, 126.01, 121.88, 
119.89, 101.79, 51.93. HRMS (ESI-QTOF) calcd for [M + H+]: 257.0808, found: 257.0810. 
Addition reactions via silyl enol ether 10; general procedure. To a stirred solution of 
dehydroacetic acid (168 mg, 1.0 mmol) in dichloromethane (5.0 mL) was added 
dimethyldichlorosilane (129 mg, 1.0 mmol) followed by triethyl amine (202 mg, 2.0 mmol) at 0 
°C. The mixture was stirred for 90 minutes at room temperature. Boron trifluoride etherate (284 
mg, 2.0 mmol) and aldehyde (2.0 mmol) were added to the flask at 0 °C and the mixture was 
stirred at 0 oC for 2 hours. Saturated ammonium chloride solution (10 mL) was added to quench 
the reaction, and the mixture was extracted with ethyl acetate (10 mL x 3). The combined 
organic layers were dried over sodium sulfate and concentrated. Purification by column 




Addition reactions via the titanium enolate; general procedure. To a stirred solution 
of dehydroacetic acid (168 mg, 1.0 mmol) in dichloromethane (5.0 mL) was added titanium 
tetrachloride (209 mg, 1.1 mmol) followed by N,N-diisopropylethylamine(284 mg, 2.2 mmol) at 
-78 °C. The mixture was stirred for 30 minutes at the temperature. Then aldehyde (1.2 mmol) 
was added to the flask and the mixture was stirred at -78 °C for 2 hours. Saturated ammonium 
chloride solution (10 mL) was added to quench the reaction, and the mixture was extracted with 
ethyl acetate (10 mL x 3). The combined organic layers were dried over sodium sulfate and 
concentrated. Purification by column chromatography on silica gel (hexane/ethyl acetate = 
10:1(v/v)) gave the product. 
 
4-Hydroxy-3-(3-hydroxy-3-phenylpropanoyl)-6-methyl-2H-pyran-2-one (11a). 
Yellow oil, 189 mg, 69% yield (by Si method). 219 mg, 80% yield (by Ti method). 1H NMR 
(400 MHz, CDCl3) δ = 7.49 - 7.39 (m, 2H), 7.40 - 7.31 (m, 2H), 7.32 - 7.24 (m, 1H), 5.97 (s, 
1H), 5.26 (dd, J=8.1, 3.9, 1H), 3.59 - 3.44 (m, 2H), 3.12 (d, J=3.9, 1H), 2.28 (s, 3H). 13C NMR 
(100 MHz, CDCl3) δ = 205.8, 181.0, 169.6, 161.3, 142.9, 128.5, 127.7, 125.8, 101.5, 100.0, 70.3, 
50.5, 20.8. HRMS (ESI-TOF) m/z: [M – H]− calcd for 273.0768; found, 273.0771. 
 
4-Hydroxy-3-(3-hydroxy-4-methylpentanoyl)-6-methyl-2H-pyran-2-one (11b). Color 
oil, 199 mg, 83% yield (by Si method.) 180 mg, 75% yield (by Ti method). 1H NMR (400 MHz, 
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CDCl3) δ = 5.96 (s, 1H), 3.90 (ddd, J=8.8, 5.5, 2.9, 1H), 3.28 - 3.22 (m, 1H), 3.17 (dd, J=16.7, 
9.3, 1H), 2.70 (s, 1H), 2.27 (s, 3H), 1.78 (pd, J=6.8, 5.6, 1H), 0.98 (d, J=4.5, 3H), 0.97 (d, J=4.5, 
3H). 13C NMR (100 MHz, CDCl3) δ = 207.5, 181.0, 169.3, 161.4, 101.5, 100.1, 72.9, 45.8, 33.6, 
20.7, 18.5, 17.6. HRMS (ESI-TOF) m/z: [M – H]− calcd for 239.0925; found, 239.0925. 
 
3-(3-Cyclohexyl-3-hydroxypropanoyl)-4-hydroxy-6-methyl-2H-pyran-2-one (11c). 
White Solid, mp 70-72 oC, 215 mg, 77% yield (by Ti method). 1H NMR (400 MHz, CDCl3) δ = 
5.96 (s, 1H), 3.91 (ddd, J=8.9, 5.8, 2.8, 1H), 3.27 (dd, J=16.7, 2.9, 1H), 3.19 (dd, J=16.7, 9.3, 
1H), 2.28 (s, 3H), 1.91 (d, J=12.8, 1H), 1.82 – 1.62 (m, 4H), 1.45 (dddt, J=11.6, 8.8, 6.0, 2.9, 
1H), 1.31 – 0.98 (m, 5H). 13C NMR (100 MHz, CDCl3) δ = 207.6, 181.0, 169.3, 161.4, 101.5, 
100.1, 72.4, 46.0, 43.5, 28.9, 28.1, 26.4, 26.2, 26.1, 20.7. HRMS (ESI-TOF) m/z: [M + H]+ calcd 
for 281.1384; found, 281.1385. 
 
4-Hydroxy-3-(3-hydroxy-4,4-dimethylpentanoyl)-6-methyl-2H-pyran-2-one (11d). 
Colorless oil, 170 mg, 67% yield (by Ti method). 1H NMR (400 MHz, CDCl3) δ = 5.95 (s, 1H), 
3.79 (d, J=10.2, 1H), 3.47 (s, 1H), 3.31 - 3.20 (m, 1H), 3.15 (m, 1H), 2.27 (s, 3H), 0.97 (s, 9H). 
13C NMR (100 MHz, CDCl3) δ = 207.8, 181.0, 169.3, 161.5, 101.5, 100.2, 75.9, 43.8, 34.9, 25.6, 





Yellow oil, 119 mg, 50% yield (by Ti method). 1H NMR (400 MHz, CDCl3) δ = 5.97 (s, 1H), 
5.08 – 5.02 (m, 1H), 4.89 (d, J=1.7, 1H), 4.64 – 4.56 (m, 1H), 3.32 (d, J=6.5, 2H), 2.81 (d, J=4.0, 
1H), 2.28 (s, 3H), 1.80 (s, 3H). 13C NMR (100 MHz, CDCl3) δ = 206.3, 181.0, 169.5, 161.4, 
146.0, 111.2, 101.5, 100.0, 71.5, 47.2, 20.7, 18.4. HRMS (ESI-TOF) m/z: [M – H]− calcd for 
237.0757; found, 237.0764. 
 
4-Hydroxy-3-(3-hydroxy-5-methylhexanoyl)-6-methyl-2H-pyran-2-one (11f). 
Colorless oil, 188 mg, 74% yield (by Ti method). 1H NMR (600 MHz, CDCl3) δ = 5.97 (s, 1H), 
4.24 (ddt, J=6.3, 4.4, 2.0, 1H), 3.30 - 3.25 (m, 1H), 3.21 - 3.14 (m, 1H), 2.73 (s, 1H), 2.29 (s, 
3H), 1.97 - 1.78 (m, 1H), 1.62 - 1.53 (m, 1H), 1.31 (ddd, J=13.8, 6.7, 3.5, 1H), 0.94 (d, J=6.8, 
6H). 13C NMR (150 MHz, CDCl3) δ = 207.0, 181.0, 169.4, 161.3, 101.5, 100.0, 66.3, 49.2, 46.1, 
24.5, 23.3, 22.1, 20.7. HRMS (ESI-TOF) m/z: [M + H]+ calcd for 255.1227; found, 255.1225. 
 
3-(2-Bromoacetyl)-4-hydroxy-6-methyl-2H-pyran-2-one (12). To a stirred solution of 
dehydroacetic acid (168 mg, 1.0 mmol) in dichloromethane (5.0 mL) was added 
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dimethyldichlorosilane (129 mg, 1.0 mmol) followed by triethyl amine (202 mg, 2.0 mmol) at 0 
°C. The mixture was stirred for 90 minutes at room temperature. N-Bromosuccinimide (356 mg, 
2.0 mmol) was added to the flask at 0 °C and the mixture was stirred at 0 oC for 2 hours. 
Saturated ammonium chloride solution (10 mL) was added to quench the reaction, and the 
mixture was extracted with ethyl acetate (10 mL x 3). The combined organic layers were dried 
over sodium sulfate and concentrated. Purification by column chromatography on silica gel 
(hexane/ethyl acetate = 10:1(v/v)) gave the product 12. White solid, mp 114-116 oC,178 mg, 
72% yield (by Si method, boron trifluoride etherate was not needed). 1H NMR (600 MHz, 
CDCl3) δ = 6.01 (s, 1H), 4.70 (s, 2H), 2.31 (s, 3H). 
13C NMR (150 MHz, CDCl3) δ = 197.3, 




(pogopyrone). To a stirred solution of 11a (137 mg, 0.5 mmol, 1.0 equiv) in dichloromethane 
(13 mL) was added Dess–Martin periodinane (DMP, 318mg, 1.5 equiv), the mixture was stirred 
at room temperature overnight. After the reaction, dichloromethane was removed by rotary. 
Purification by column chromatography on silica gel (hexane/ethyl acetate = 10:1(v/v)) gave the 
product. Yellow solid, 116 mg, 78% yield. 1H NMR (400 MHz, CDCl3) δ = 8.12 - 7.91 (m, 2H), 
7.73 (s, 1H), 7.54 - 7.46 (m, 1H), 7.46 (d, J=7.8, 2H), 5.93 (s, 1H), 2.25 (s, 3H). 13C NMR (100 
MHz, CDCl3) δ = 193.3, 180.0, 177.6, 167.8, 160.9, 133.5, 132.5, 128.7, 127.2, 101.8, 97.6, 
95.6, 20.5. HRMS (ESI-TOF) m/z: [M + H]+ calcd for 273.0757; found, 273.0757. 
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CHAPTER 3.    GENERAL CONCLUSION 
Four natural products and their derivatives exhibiting antibacterial activities were 
synthesized. The first synthesis of biatriosporin D was accomplished in six steps. The overall 
yield is 50% and the key steps are a carbonyl diimidazole mediated acylation and lithium 
chloride promoted demethylation. The first synthesis of indanostatin was accomplished in six 
steps.  The overall yield is 15%. Key steps are the Hauser-Kraus annulation and the N-
bromosuccinimide and dimethyl sulfoxide oxidation. The first synthesis of dihydro eurotiumide 
B was accomplished in seven steps. The overall yield is 30%. Key steps are the tandem Hauser-
Kraus annulation-reductive thiolation reaction.  Naphthacemycin A9 was synthesized in nine 
steps, the overall yield is in 26%. The key steps are the Diels-Alder reaction and the Hauser-
Kraus annulation. 
In the second chapter, the transformations of the methyl comalate and dehydroacetic acid 
provided a variety of biobased compounds. The two-step Diels-Alder/aromatization pathway to 
substituted isophthalates proceeds in high overall yields and is operationally convenient. 
Selective aldol reactions at the acetyl group of dehydroacetic acid have been achieved via the 
either silyl enol ether or the titanium enolate. A direct synthesis of pogopyrone A was achieved. 
 
 
